0001193125-23-300556.txt : 20231221 0001193125-23-300556.hdr.sgml : 20231221 20231221092053 ACCESSION NUMBER: 0001193125-23-300556 CONFORMED SUBMISSION TYPE: N-CSR PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20231031 FILED AS OF DATE: 20231221 DATE AS OF CHANGE: 20231221 EFFECTIVENESS DATE: 20231221 FILER: COMPANY DATA: COMPANY CONFORMED NAME: T. Rowe Price International Funds, Inc. CENTRAL INDEX KEY: 0000313212 ORGANIZATION NAME: IRS NUMBER: 521175211 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: N-CSR SEC ACT: 1940 Act SEC FILE NUMBER: 811-02958 FILM NUMBER: 231503020 BUSINESS ADDRESS: STREET 1: 100 EAST PRATT STREET CITY: BALTIMORE STATE: MD ZIP: 21202 BUSINESS PHONE: 410-345-2000 MAIL ADDRESS: STREET 1: 100 EAST PRATT STREET CITY: BALTIMORE STATE: MD ZIP: 21202 FORMER COMPANY: FORMER CONFORMED NAME: PRICE T ROWE INTERNATIONAL FUNDS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: PRICE T ROWE INTERNATIONAL TRUST DATE OF NAME CHANGE: 19900301 FORMER COMPANY: FORMER CONFORMED NAME: PRICE T ROWE INTERNATIONAL FUND INC DATE OF NAME CHANGE: 19890914 0000313212 S000001488 T. Rowe Price Emerging Europe Fund C000004006 T. Rowe Price Emerging Europe Fund TREMX C000184316 T. Rowe Price Emerging Europe Fund-I Class TTEEX C000225806 T. Rowe Price Emerging Europe Fund-Z Class TRZEX N-CSR 1 d935618dncsr.htm EMERGING EUROPE FUND_EEM_F131-050 Emerging Europe Fund_EEM_F131-050

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM N-CSR

CERTIFIED SHAREHOLDER REPORT OF REGISTERED

MANAGEMENT INVESTMENT COMPANIES

Investment Company Act File Number: 811-02958

T. Rowe Price International Funds, Inc.

 

(Exact name of registrant as specified in charter)

100 East Pratt Street, Baltimore, MD 21202

 

(Address of principal executive offices)

David Oestreicher

100 East Pratt Street, Baltimore, MD 21202

 

(Name and address of agent for service)

Registrant’s telephone number, including area code: (410) 345-2000

Date of fiscal year end: October 31

Date of reporting period: October 31, 2023


Item 1. Reports to Shareholders

(a) Report pursuant to Rule 30e-1

 


Highlights
and
Market
Commentary
Management’s
Discussion
of
Fund
Performance
Performance
and
Expenses
Financial
Highlights
Portfolio
of
Investments
Financial
Statements
and
Notes
Additional
Fund
Information
October
31,
2023
Annual
Report
For
more
insights
from
T.
Rowe
Price
investment
professionals,
go
to
troweprice.com
.
T.
ROWE
PRICE
TREMX
Emerging
Europe
Fund
.
TTEEX
Emerging
Europe
Fund–
.
I  Class
TRZEX
Emerging
Europe
Fund–
.
Z Class
T.
ROWE
PRICE
Emerging
Europe
Fund
HIGHLIGHTS
Both
the
portfolio
and
the
benchmark
index
registered
significant
gains
over
the
12-month
period
ended
October
31,
2023.
On
a
country
basis,
Russia
made
the
biggest
contribution
to
the
portfolio’s
relative
performance
over
the
review
period
as
we
realized
gains
from
selling
ADRs.
Our
positioning
in
Türkiye
1
was
also
beneficial.
We
increased
our
exposure
to
Türkiye,
moving
from
a
significant
underweight
position
to
a
small
overweight
allocation.
This
reflects
the
country’s
convincing
post-election
shift
to
more
orthodox
monetary
and
fiscal
policies.
We
remain
overweight
to
Greece
and
have
an
underweight
allocation
to
Poland.
We
maintain
a
long-term
investment
horizon
and
exposure
to
well-managed
companies
that
we
think
can
deliver
good
levels
of
profit
growth
and/or
free
cash
flow
generation
over
time.
1
The
United
Nations
recently
adopted
a
new
name
for
the
country
officially
recognized
as
Turkey—
"Türkiye."
Our
firm
has
adopted
the
new
naming
convention
as
of
September
2023.
Log
in
to
your
account
at
troweprice.com
for
more
information.
*
An
account
service
fee
will
be
charged
annually
for
each
T.
Rowe
Price
mutual
fund
account
unless
you
meet
criteria
for
a
fee
waiver.
Go
to
troweprice.com/personal-investing/help/fees-and-
minimums.html
to
learn
more
about
this
account
service
fee,
including
other
ways
to
waive
it.
T.
ROWE
PRICE
Emerging
Europe
Fund
Market
Commentary
1
Dear
Shareholder
Most
major
global
stock
and
bond
indexes
produced
positive
results
during
your
fund’s
fiscal
year,
the
12-month
period
ended
October
31,
2023,
although
a
downturn
over
the
past
six
months
offset
some
of
the
strong
gains
recorded
in
the
first
half
of
the
period.
Global
economies
managed
to
avoid
the
recession
that
was
widely
predicted
at
the
start
of
2023,
but
signs
that
central
banks
might
need
to
keep
interest
rates
higher
for
longer
than
previously
expected
weighed
on
market
sentiment.
Growth
stocks
outperformed
value
shares
over
the
12-month
period,
and
stocks
in
developed
markets
generally
outpaced
their
counterparts
in
emerging
markets.
Currency
movements
were
mixed
over
the
period,
although
a
weaker
dollar
versus
major
European
currencies
was
beneficial
for
U.S.
investors
in
European
securities.
Technology
companies
benefited
from
investor
enthusiasm
for
artificial
intelligence
developments
and
produced
some
of
the
strongest
results
in
the
equity
market.
Within
the
S&P
500
Index,
the
communication
services
and
information
technology
sectors
were
lifted
by
the
rally
in
tech-related
companies
and
recorded
significant
gains.
The
financials
sector
partly
recovered
from
the
failure
of
three
large
regional
banks
during
the
period
but
still
finished
in
negative
territory.
Corporate
fundamentals
were
broadly
supportive.
Although
year-over-year
earnings
growth
contracted
in
the
first
and
second
quarters
of
2023,
results
were
better
than
expected,
and
preliminary
estimates
pointed
to
a
resumption
of
growth
in
the
third
quarter.
The
U.S.
economy
was
the
strongest
among
the
major
markets
during
the
period,
with
gross
domestic
product
growth
coming
in
at
4.9%
in
the
third
quarter’s
initial
estimate,
the
highest
since
the
end
of
2021.
Growth
in
Europe
and
Japan
was
more
sluggish,
and
China’s
economy
was
beset
by
worries
about
its
property
sector
after
an
initial
boost
from
its
decision
at
the
end
of
2022
to
lift
most
of
its
pandemic-related
restrictions.
A
protracted
debt
ceiling
standoff
in
the
U.S.,
the
ongoing
conflict
between
Ukraine
and
Russia,
and
the
outbreak
of
war
in
the
Middle
East
following
the
attack
on
Israel
by
Hamas
produced
headwinds
for
markets
at
various
times.
Investors
also
remained
focused
on
inflation
as
price
increases
moderated
but
remained
well
above
the
Federal
Reserve’s
2%
target.
In
response,
the
Fed
continued
to
raise
its
short-term
lending
benchmark
rate,
lifting
it
to
a
target
range
of
5.25%
to
5.50%
by
the
end
of
July,
the
highest
level
since
March
2001.
T.
ROWE
PRICE
Emerging
Europe
Fund
2
U.S.
Treasury
yields
increased
as
the
Fed
tightened
monetary
policy
and
investors
priced
in
the
possibility
that
the
central
bank
may
have
to
keep
rates
higher
for
longer
than
previously
anticipated.
In
addition,
Treasuries
were
pressured
by
Fitch
Ratings’
decision
to
downgrade
the
credit
rating
of
U.S.
government
debt
from
the
highest
level,
AAA,
to
AA+
along
with
expectations
for
higher
levels
of
borrowing
by
the
Treasury
Department.
The
yield
on
the
benchmark
10-year
Treasury
note
briefly
reached
5.00%
in
October
for
the
first
time
since
late
2007
before
falling
back
to
4.88%
by
period-end.
Increasing
yields
over
the
past
six
months
led
to
weak
results
across
most
of
the
fixed
income
market,
although
high
yield
bonds,
which
are
less
sensitive
to
rising
rates,
held
up
relatively
well
as
default
rates
remained
low
by
historical
standards.
Global
economies
and
markets
showed
surprising
resilience
in
2023,
but
considerable
uncertainty
remains
as
we
look
ahead
to
2024.
Geopolitical
events,
the
path
of
monetary
policy,
and
the
impact
of
the
Fed’s
rate
hikes
on
the
economy
all
raise
the
potential
for
additional
volatility.
We
believe
this
environment
makes
skilled
active
management
a
critical
tool
for
identifying
risks
and
opportunities,
and
our
investment
teams
will
continue
to
use
fundamental
research
to
identify
securities
that
have
the
potential
to add
value
to
your
portfolio
over
the
long
term.
Thank
you
for
your
continued
confidence
in
T.
Rowe
Price.
Sincerely,
Robert
Sharps
CEO
and
President
T.
ROWE
PRICE
Emerging
Europe
Fund
Management’s
Discussion
of
Fund
Performance
3
INVESTMENT
OBJECTIVE 
The
fund
seeks
long-term
growth
of
capital
through
investments
primarily
in
the
common
stocks
of
companies
located
(or
with
primary
operations)
in
the
emerging
market
countries
of
Europe.
FUND
COMMENTARY
How
did
the
fund
perform
in
the
past 12
months?
The
Emerging
Europe
Fund
returned
61.05%
in
the
12-month
period
ended
October
31,
2023.
As
shown
in
the
Performance
Comparison
table,
the
fund
outperformed
the
MSCI
Emerging
Markets
Europe
Index
Net.
(Returns
for
the
I
and
Z
Class
shares
will
vary,
reflecting
their
different
fee
structures.
Past
performance
cannot
guarantee
future
results
.
)
Investors
should
note
that
the
fund’s
short-term
performance
is
highly
unusual
and
unlikely
to
be
sustained.
What
factors
influenced
the
fund’s
performance?
The
strong
absolute
return
of
the
fund
and
benchmark
index
over
the
12-month
review
period
followed
the
very
sharp
fall
in
both
over
the
preceding
one-year
period.
On
a
country
basis,
Russia
made
the
biggest
contribution
to
the
portfolio’s
relative
performance
over
the
review
period.
As
background,
following
the
invasion
of
Ukraine
by
Russian
armed
forces
in
February
2022,
index
provider
MSCI
announced
that
it
was
removing
Russian
securities
from
its
MSCI
emerging
markets
indices,
including
the
fund’s
benchmark,
at
a
price
that
was
effectively
zero.
Subsequently,
over
the
most
recent
12
months,
we
have
been
able
to
realize
some
gains,
selling
some
of
our
Russian
American
Depository
Receipts
(ADRs)
to
brokers
at
a
discount
to
their
market
value
in
the
domestic
Russian
market.
These
were
specific
companies
against
which
there
were
no
U.S.
sanctions,
including
e-commerce
operation
Ozon,
technology
companies
VK
and
Yandex,
and
HeadHunter
Group.
(We
have
also
received
dividends
from
Russian
companies,
but
due
to
capital
controls
set
by
the
Russian
central
PERFORMANCE
COMPARISON
Total
Return
Periods
Ended
10/31/23
6
Months
12
Months
Emerging
Europe
Fund
.
13.58‌%
61.05‌%
Emerging
Europe
Fund–
.
I  Class
13.71‌
61.64‌
Emerging
Europe
Fund–
.
Z  Class
14.42‌
63.65‌
MSCI
Emerging
Markets
Europe
Index
Net
9.21‌
44.34‌
T.
ROWE
PRICE
Emerging
Europe
Fund
4
bank,
we
cannot
access
these
local
financial
assets
until
or
if
the
controls
are
removed.
They
are
currently
valued
at
zero.)
(Please
refer
to
the
portfolio
of
investments
for
a
complete
list
of
holdings
and
the
amount
each
represents
in
the
portfolio.)
Beyond
Russia,
Türkiye
contributed
significantly
to
relative
results,
due
to
both
our
choice
of
securities
and
allocation
to
this
market.
At
the
beginning
of
the
review
period,
we
were
significantly
underweight
Türkiye
due
to
our
cautious
outlook
about
the
economic
and
political
direction
of
the
country.
This
served
performance
well
early
in
the
review
period
as
the
country
underperformed
on
the
back
of
a
weakening
lira.
As
the
review
period
progressed,
we
increased
our
exposure
to
Türkiye
to
a
small
overweight
following
the
post-election
shift
in
monetary
policy
in
mid-2023.
The
market
has
rallied
strongly
since
then,
greatly
benefiting
the
portfolio’s
relative
performance.
Greece
also
contributed
to
relative
performance,
due
to
our
overweight
allocation
to
this
outperforming
market.
Our
position
in
National
Bank
of
Greece
was
particularly
beneficial;
sentiment
toward
the
Greek
banking
sector
continued
to
be
boosted
by
continued
securitization
and
sales
of
non-
performing
loan
exposures
by
the
banks,
helped
by
the
Greek
government’s
guarantees,
as
well
as
better
performance
of
net
interest
income
and
asset
quality
overall.
Conversely,
the
portfolio’s
underweight
to
Poland
hindered
performance,
as
the
Polish
equity
market
outperformed
the
broader
benchmark
index.
At
the
stock
level,
our
lack
of
exposure
to
domestic
banking
names
Bank
Pekao
and
PKO
Bank
Polski
hindered
returns
on
a
relative
basis
as
their
shares
soared
over
the
period
on
the
back
of
improved
sentiment
toward
the
sector.
How
is
the
fund
positioned?
One
of
the
key
shifts
in
our
positioning
over
the
period
has
been
to
move
from
a
longstanding
significant
underweight
to
a
small
overweight
allocation
to
Türkiye.
This
reflects
the
convincing
shift
to
more
orthodox
monetary
and
fiscal
policies
and
the
appointment
of
a
new
and
more
investor-friendly
finance
minister
in
June
2023
who
has
pledged
“transparency,
consistency,
predictability,
and
compliance
with
international
norms.”
Following
the
sharp
deprecation
of
the
lira
in
June,
we
began
adding
to
positions
in
the
country
in
July
and
August
2023.
Since
the
elections,
the
central
bank
has
embarked
on
a
serious
fight
against
inflation,
raising
interest
rates
from
8%
to
35%,
significantly
reducing
the
risk
of
further
currency
depreciation.
T.
ROWE
PRICE
Emerging
Europe
Fund
5
Additions
to
the
portfolio
in
Türkiye
included
consumer
names
such
as
index
heavyweight
BIM
Birlesik
Magazalar,
a
retailer
of
basic
food
and
consumer
goods.
We
also
initiated
a
position
in
industrial
conglomerate
KOC
Holding,
which
is
one
of
the
more
liquid
names
in
the
country
and
which
gives
good
exposure
to
the
overall
Turkish
economy.
We
added
to
our
position
in
D-Market
Elektronik
Hizmetler,
usually
known
as
Hepsiburada.
The
e-commerce
platform
recently
pleased
investors
with
a
return
to
profitability
and
is
undervalued
compared
with
its
sectoral
peers.
Elsewhere,
our
positioning
has
not
changed
meaningfully
over
the
past
year.
The
fund
retains
a
sizable
overweight
to
Greece.
Our
favorable
view
is
predicated
on
a
number
of
factors.
We
believe
the
current
Greek
government,
which
came
to
power
in
2019,
has
undertaken
the
fiscal
and
structural
reforms
that
we
believe
are
necessary.
Our
main
active
positions
are
in
the
banking
sector,
notably
National
Bank
of
Greece
and
Eurobank.
We
also
have
an
off-benchmark
overweight
in
Kazakhstan.
Our
main
positions
here
include
Halyk
Savings
Bank
of
Kazakhstan
and
fintech
and
e-commerce
platform
Kaspi.
We
trimmed
our
positions
in
both
to
manage
the
extent
of
our
exposure
to
each
and
to
limit
the
portfolio’s
concentration
to
particular
sectors.
We
are
also
underweight
Poland,
and
our
positioning
has
not
significantly
changed
over
the
review
period.
Polish
banks
face
a
competitive
landscape,
and
valuations
are
not
particularly
attractive.
In
the
past,
there
has
been
government
meddling
in
this
sector,
but
there
is
the
potential
for
this
to
improve
under
the
new
government.
We
bought
a
new
position
in
mBank;
its
profitability
should
start
to
improve
now
that
the
Swiss
franc-based
mortgage
provisioning
headwinds
are
easing.
We
struggle
to
find
high-quality,
reasonably
SECTOR
DIVERSIFICATION
Percent
of
Net
Assets
4/30/23
10/31/23
Financials
48.3‌%
44.1‌%
Industrials
and
Business
Services
14.2‌
14.2‌
Consumer
Discretionary
10.1‌
14.0‌
Consumer
Staples
6.2‌
7.6‌
Energy
3.4‌
6.3‌
Communication
Services
6.1‌
4.8‌
Materials
0.7‌
3.1‌
Health
Care
2.5‌
2.3‌
Real
Estate
2.8‌
1.7‌
Utilities
3.1‌
1.4‌
Information
Technology
0.3‌
0.1‌
Other
and
Reserves
2.3‌
0.4‌
Total
100.0‌%
100.0‌%
Historical
weightings
reflect
current
industry/sector
classifications.
T.
ROWE
PRICE
Emerging
Europe
Fund
6
priced,
or
otherwise
compelling
investment
opportunities
beyond
the
banks,
with
many
companies
subject
to
state
influence
and
regulatory
controls.
However,
we
are
carefully
monitoring
the
situation,
particularly
the
potential
for
a
more
market-friendly
government
following
recent
elections.
We
made
no
significant
changes
in
Hungary,
keeping
an
overweight
in
OTP;
we
continue
to
like
the
story
at
the
bank,
the
valuation
remains
reasonable
relative
to
its
Polish
and
Czech
peers,
and
the
stock
has
performed
well.
What
is
portfolio
management’s
outlook?
Our
outlook
for
Türkiye
has
evolved
in
recent
months
following
the
reelection
of
President
Recep
Tayyip
Erdogan
and
the
adoption
of
more
orthodox
policies.
Although
the
macroeconomic
and
geopolitical
backdrop
remains
challenging,
we
are
very
encouraged
by
recent
policy
changes
and
the
appointment
of
Mehmet
Simsek,
a
more
market-friendly
finance
minister.
We
have
taken
the
view
that
these
changes
are
likely
to
continue
at
least
in
the
short
term.
We
also
believe
that
following
the
significant
depreciation
in
the
lira
leading
up
to
the
2023
elections,
the
risk
of
future
fluctuations
in
the
currency
are
likely
to
be
more
in
line
with
inflation
and
more
manageable.
The
central
bank
is
adopting
a
more
realistic
approach
to
inflation
expectations,
and
we
will
monitor
whether
this
feeds
through
into
positive
inflation
dynamics.
There
is
the
potential
for
inflation
to
come
down
meaningfully
from
the
second
half
of
2024
onwards.
We
continue
to
monitor
the
situation
carefully.
The
portfolio
retains
an
overweight
with
respect
to
Greece.
We
remain
optimistic
about
the
country
on
a
top-down
view
and
are
encouraged
by
the
government’s
pro-business,
pro-reforms
approach.
We
remain
underweight
Poland.
Although
Poland’s
economy
is
generally
solid,
the
attractiveness
of
this
market
has
been
hindered
in
recent
years
by
the
government’s
market-unfriendly
policies.
The
parliamentary
election
victory
by
three
pro-EU
parties
in
October
2023
is
encouraging
as
it
raises
the
possibility
of
a
more
market-friendly
and
EU-oriented
government
there. We
continue
to
monitor
this
development
carefully,
but
we
still
struggle
to
find
good
investment
opportunities
on
a
bottom-up
basis.
Many
of
the
large
stocks
in
this
market
are
lower-quality
state-owned
enterprises.
Elsewhere,
we
believe
our
frontier
market
positions,
such
as
Kazakhstan,
continue
to
offer
long-term
growth
potential
at
attractive
valuations
and
help
us
to
diversify
the
portfolio.
We
maintain
a
long-term
investment
horizon
and
exposure
to
well-managed
companies
that
we
think
can
deliver
good
levels
of
profit
growth
and/or
free
cash
flow
generation
over
time.
In
our
view,
valuations
in
emerging
Europe
remain
at
attractive
levels.
T.
ROWE
PRICE
Emerging
Europe
Fund
7
After
careful
consideration,
T.
Rowe
Price
decided
to
close
the
T.
Rowe
Price
Emerging
Europe
Fund
to
all
purchases
effective
February
17,
2023,
at
the
close
of
the
New
York
Stock
Exchange.
All
purchase
and
exchange
activity
into
the
fund,
including
purchases
from
existing
shareholders,
was
halted
(i.e.,
hard
close).
There
was
no
exception
for
plan
participants
in
retirement
plans
where
the
fund
was
an
existing
option.
As
we
advised
in
last
year’s
shareholder
letter,
the
fund
had
previously
closed
to
new
investors
under
a
capacity
level
4
rating
(i.e.,
“soft
close”)
on
May
9,
2022.
The
views
expressed
reflect
the
opinions
of
T.
Rowe
Price
as
of
the
date
of
this
report
and
are
subject
to
change
based
on
changes
in
market,
economic,
or
other
conditions.
These
views
are
not
intended
to
be
a
forecast
of
future
events
and
are
no
guarantee
of
future
results.
T.
ROWE
PRICE
Emerging
Europe
Fund
8
RISKS
OF
INVESTING
IN
EMERGING
EUROPE
The
February
2022
invasion
of
Ukraine
by
Russia
has
clearly
heightened
the
risks
associated
with
investing
in
this
region.
More
generally,
economic
and
political
structures
in
many
emerging
European
countries
are
in
the
early
stages
of
economic
development
and
developing
rapidly,
and
such
countries
may
lack
the
social,
political,
and
economic
stability
characteristic
of
many
more
developed
countries.
In
addition,
the
small
size
and
inexperience
of
the
securities
markets
in
emerging
European
countries
and
the
limited
volume
of
trading
in
securities
in
those
markets
may
make
the
fund’s
investments
in
such
countries
illiquid
and
more
volatile
than
investments
in
more
developed
countries
and
may
make
obtaining
prices
on
portfolio
securities
from
independent
sources
more
difficult
than
in
other
more
developed
markets.
In
the
past,
certain
emerging
European
countries
have
failed
to
recognize
private
property
rights
and
at
times
have
nationalized
or
expropriated
the
assets
of
private
companies.
There
may
also
be
little
financial
or
accounting
information
available
with
respect
to
companies
located
in
certain
Eastern
European
countries,
which,
as
a
result,
may
make
it
difficult
to
assess
the
value
or
prospects
of
an
investment
in
such
companies.
RISKS
OF
INVESTING
IN
EMERGING
MARKETS
Investments
in
emerging
markets
are
subject
to
the
risk
of
abrupt
and
severe
price
declines.
The
economic
and
political
structures
of
emerging
market
countries,
in
most
cases,
do
not
compare
favorably
with
the
U.S.
or
other
developed
countries
in
terms
of
wealth
and
stability,
and
their
financial
markets
often
lack
liquidity.
These
economies
are
less
developed,
can
be
overly
reliant
on
particular
industries,
and
are
more
vulnerable
to
the
ebb
and
flow
of
international
trade,
trade
barriers,
and
other
protectionist
or
retaliatory
measures.
Governments
in
many
emerging
market
countries
participate
to
a
significant
degree
in
their
economies
and
securities
markets.
As
a
result,
foreign
investments
may
be
restricted
and
subject
to
greater
government
control,
including
repatriation
of
sales
proceeds.
Emerging
market
securities
exchanges
are
more
likely
to
experience
problems
with
the
clearing
and
settling
of
trades,
as
well
as
the
custody
of
holdings
by
local
banks,
agents,
and
depositories.
In
addition,
the
accounting
standards
in
emerging
market
countries
may
be
unreliable
and
could
present
an
inaccurate
picture
of
a
company’s
finances.
Some
countries
have
histories
of
instability
and
upheaval
that
could
cause
their
governments
to
act
in
a
detrimental
or
hostile
manner
toward
private
enterprise
or
foreign
investment.
Investments
in
countries
or
regions
that
have
recently
begun
moving
away
from
central
planning
and
state-owned
industries
toward
free
markets
should
be
regarded
as
speculative.
T.
ROWE
PRICE
Emerging
Europe
Fund
9
RISKS
OF
NONDIVERSIFICATION
Because
the
fund
is
nondiversified
and
thus
can
invest
more
of
its
assets
in
a
smaller
number
of
issuers,
it
is
more
exposed
to
the
risks
associated
with
an
individual
issuer
than
a
fund
that
invests
more
broadly
across
many
issuers.
For
example,
poor
performance
by
a
single
large
holding
of
the
fund
would
adversely
affect
the
fund’s
performance
more
than
if
the
fund
were
invested
in
a
larger
number
of
issuers.
These
are
some
of
the
principal
risks
of
investing
in
this
fund.
For
a
more
thorough
discussion
of
risks,
please
see
the
fund’s
prospectus.
BENCHMARK
INFORMATION
Note:
MSCI
and
its
affiliates
and
third-party
sources
and
providers
(collectively,
“MSCI”)
makes
no
express
or
implied
warranties
or
representations
and
shall
have
no
liability
whatsoever
with
respect
to
any
MSCI
data
contained
herein.
The
MSCI
data
may
not
be
further
redistributed
or
used
as
a
basis
for
other
indices
or
any
securities
or
financial
products.
This
report
is
not
approved,
reviewed,
or
produced
by
MSCI.
Historical
MSCI
data
and
analysis
should
not
be
taken
as
an
indication
or
guarantee
of
any
future
performance
analysis,
forecast
or
prediction.
None
of
the
MSCI
data
is
intended
to
constitute
investment
advice
or
a
recommendation
to
make
(or
refrain
from
making)
any
kind
of
investment
decision
and
may
not
be
relied
on
as
such.
T.
ROWE
PRICE
Emerging
Europe
Fund
10
PORTFOLIO
HIGHLIGHTS
TWENTY-FIVE
LARGEST
HOLDINGS
Percent
of
Net
Assets
10/31/23
National
Bank
of
Greece,
Greece
13.5‌%
OTP
Bank,
Hungary
8.5‌ 
KOC
Holding,
Türkiye
6.5‌ 
BIM
Birlesik
Magazalar,
Türkiye
6.4‌ 
D-MARKET
Elektronik
Hizmetler
ve
Ticaret,
Türkiye
6.3‌ 
Eurobank
Ergasias
Services
&
Holdings,
Greece
4.7‌
Powszechny
Zaklad
Ubezpieczen,
Poland
4.7‌
Türkiye
Petrol
Rafinerileri,
Türkiye
4.5‌
Halyk
Savings
Bank
of
Kazakhstan,
Kazakhstan
4.1‌
InPost,
Poland
3.2‌
Turk
Hava
Yollari
AO,
Türkiye
3.2‌
OPAP,
Greece
3.1‌
JUMBO,
Greece
2.8‌
Turkcell
Iletisim
Hizmetleri,
Türkiye
2.7‌
Eregli
Demir
ve
Celik
Fabrikalari,
Türkiye
2.5‌
Kaspi.KZ,
Kazakhstan
2.4‌
Richter
Gedeon,
Hungary
2.4‌
Georgia
Capital,
United
Kingdom
2.2‌
Baltic
Classifieds
Group,
United
Kingdom
2.1‌
Allegro.eu,
Poland
1.8‌
Motor
Oil
Hellas
Corinth
Refineries,
Greece
1.8‌
LAMDA
Development,
Greece
1.7‌
Powszechna
Kasa
Oszczednosci
Bank
Polski,
Poland
1.5‌
Alpha
Services
and
Holdings,
Greece
1.3‌
Jeronimo
Martins,
Portugal
1.3‌
Total
95.2‌%
Note:
The
information
shown
does
not
reflect
any
exchange-traded
funds
(ETFs),
cash
reserves,
or
collateral
for
securities
lending
that
may
be
held
in
the
portfolio.
T.
ROWE
PRICE
Emerging
Europe
Fund
11
GROWTH
OF
$10,000 
This
chart
shows
the
value
of
a
hypothetical
$10,000
investment
in
the
fund
over
the
past
10
fiscal
year
periods
or
since
inception
(for funds
lacking
10-year
records).
The
result
is
compared
with
benchmarks,
which
include
a
broad-based
market
index
and
may
also
include
a
peer
group
average
or
index.
Market
indexes
do
not
include
expenses,
which
are
deducted
from
fund returns
as
well
as
mutual fund
averages
and
indexes.
EMERGING
EUROPE
FUND 
Note:
Performance
for
the I
and
Z Class
shares
will
vary
due
to
their
differing
fee
structures.
See
the
Average
Annual
Compound
Total
Return
table. 
AVERAGE
ANNUAL
COMPOUND
TOTAL
RETURN
Periods
Ended
10/31/23
1
Year
5
Years
10
Years
Since
Inception
Inception
Date
Emerging
Europe
Fund
.
61.05‌%
-21.13‌%
-13.94‌%
–‌
Emerging
Europe
Fund–
.
I  Class
61.64‌
-20.89‌
–‌
-15.38‌%
3/6/17
Emerging
Europe
Fund–
.
Z  Class
63.65‌
–‌
–‌
-39.13‌
2/22/21
This
table
shows
how
the
fund
would
have
performed
each
year
if
its
actual
(or
cumulative)
returns
for
the
periods
shown
had
been
earned
at
a
constant
rate.
Returns
do
not
reflect
taxes
that
the
shareholder
may
pay
on
fund
distributions
or
the
redemption
of
fund
shares.
Past
performance
cannot
guarantee
future
results.
T.
ROWE
PRICE
Emerging
Europe
Fund
12
EXPENSE
RATIO
FUND
EXPENSE
EXAMPLE
As
a
mutual
fund
shareholder,
you
may
incur
two
types
of
costs:
(1)
transaction
costs,
such
as
redemption
fees
or
sales
loads,
and
(2)
ongoing
costs,
including
management
fees,
distribution
and
service
(12b-1)
fees,
and
other
fund
expenses.
The
following
example
is
intended
to
help
you
understand
your
ongoing
costs
(in
dollars)
of
investing
in
the
fund
and
to
compare
these
costs
with
the
ongoing
costs
of
investing
in
other
mutual
funds.
The
example
is
based
on
an
investment
of
$1,000
invested
at
the
beginning
of
the
most
recent
six-month
period
and
held
for
the
entire
period.
Please
note
that
the
fund
has
three
share
classes:
The
original
share
class
(Investor
Class)
charges
no
distribution
and
service
(12b-1)
fee,
I
Class
shares
are
also
available
to
institutionally
oriented
clients
and
impose
no
12b-1
or
administrative
fee
payment,
and
Z
Class
shares
are
offered
only
to
funds
advised
by
T.
Rowe
Price
and
other
advisory
clients
of
T.
Rowe
Price
or
its
affiliates
that
are
subject
to
a
contractual
fee
for
investment
management
services
and
impose
no
12b-1
fee
or
administrative
fee
payment.
Each
share
class
is
presented
separately
in
the
table.
Actual
Expenses
The
first
line
of
the
following
table
(Actual)
provides
information
about
actual
account
values
and
expenses
based
on
the
fund’s
actual
returns.
You
may
use
the
information
on
this
line,
together
with
your
account
balance,
to
estimate
the
expenses
that
you
paid
over
the
period.
Simply
divide
your
account
value
by
$1,000
(for
example,
an
$8,600
account
value
divided
by
$1,000
=
8.6),
then
multiply
the
result
by
the
number
on
the
first
line
under
the
heading
“Expenses
Paid
During
Period”
to
estimate
the
expenses
you
paid
on
your
account
during
this
period.
Hypothetical
Example
for
Comparison
Purposes
The
information
on
the
second
line
of
the
table
(Hypothetical)
is
based
on
hypothetical
account
values
and
expenses
derived
from
the
fund’s
actual
expense
ratio
and
an
assumed
5%
per
year
rate
of
return
before
expenses
(not
the
fund’s
actual
return).
You
may
compare
the
ongoing
costs
of
investing
in
the
fund
with
other
funds
by
contrasting
this
5%
hypothetical
example
and
the
5%
hypothetical
examples
that
appear
in
the
shareholder
reports
of
the
other
funds.
The
hypothetical
account
values
and
expenses
may
not
be
used
to
estimate
the
actual
ending
account
balance
or
expenses
you
paid
for
the
period.
Emerging
Europe
Fund
2.67‌%
Emerging
Europe
Fund–I
Class
2.57‌ 
Emerging
Europe
Fund–Z
Class
1.80‌ 
The
expense
ratio
shown
is
as
of
the
fund’s
most
recent
prospectus.
This
number
may
vary
from
the
expense
ratio
shown
elsewhere
in
this
report
because
it
is
based
on
a
different
time
period
and,
if
applicable,
includes
acquired
fund
fees
and
expenses
but
does
not
include
fee
or
expense
waivers.
T.
ROWE
PRICE
Emerging
Europe
Fund
13
Note:
T.
Rowe
Price
charges
an
annual
account
service
fee
of
$20,
generally
for
accounts
with
less
than
$10,000.
The
fee
is
waived
for
any
investor
whose
T.
Rowe
Price
mutual
fund
accounts
total
$50,000
or
more;
accounts
electing
to
receive
electronic
delivery
of
account
statements,
transaction
confirmations,
prospectuses,
and
shareholder
reports;
or
accounts
of
an
investor
who
is
a
T.
Rowe
Price
Personal
Services
or
Enhanced
Personal
Services
client
(enrollment
in
these
programs
generally
requires
T.
Rowe
Price
assets
of
at
least
$250,000).
This
fee
is
not
included
in
the
accompanying
table.
If
you
are
subject
to
the
fee,
keep
it
in
mind
when
you
are
estimating
the
ongoing
expenses
of
investing
in
the
fund
and
when
comparing
the
expenses
of
this
fund
with
other
funds.
You
should
also
be
aware
that
the
expenses
shown
in
the
table
highlight
only
your
ongoing
costs
and
do
not
reflect
any
transaction
costs,
such
as
redemption
fees
or
sales
loads.
Therefore,
the
second
line
of
the
table
is
useful
in
comparing
ongoing
costs
only
and
will
not
help
you
determine
the
relative
total
costs
of
owning
different
funds.
To
the
extent
a
fund
charges
transaction
costs,
however,
the
total
cost
of
owning
that
fund
is
higher.
EMERGING
EUROPE
FUND
Beginning
Account
Value
5/1/23
Ending
Account
Value
10/31/23
Expenses
Paid
During
Period*
5/1/23
to
10/31/23
Investor
Class
Actual
$1,000.00
$1,135.80
$7.86
Hypothetical
(assumes
5%
return
before
expenses)
 1,000.00
  1,017.85
  7.43
I
Class
Actual
  1,000.00
  1,137.10
  6.09
Hypothetical
(assumes
5%
return
before
expenses)
 1,000.00
  1,019.51
  5.75
Z
Class
Actual
  1,000.00
  1,144.20
  0.27
Hypothetical
(assumes
5%
return
before
expenses)
 1,000.00
  1,024.95
  0.26
*
Expenses
are
equal
to
the
fund’s
annualized
expense
ratio
for
the
6-month
period,
multiplied
by
the
average
account
value
over
the
period,
multiplied
by
the
number
of
days
in
the
most
recent
fiscal
half
year
(184),
and
divided
by
the
days
in
the
year
(365)
to
reflect
the
half-year
period.
The
annualized
expense
ratio
of
the
1
Investor
Class
was
1.46%,
the
2
I Class
was
1.13%,
and
the
3
Z Class
was
0.05%.
FUND
EXPENSE
EXAMPLE
(CONTINUED)
T.
ROWE
PRICE
Emerging
Europe
Fund
14
QUARTER-END
RETURNS
Periods
Ended
9/30/23
1
Year
5
Years
10
Years
Since
Inception
Inception
Date
Emerging
Europe
Fund
.
88.07‌%
-21.43‌%
-13.27‌%
–‌
Emerging
Europe
Fund–
.
I  Class
89.22‌ 
-21.14‌ 
–‌
-15.05‌%
3/6/17
Emerging
Europe
Fund–
.
Z  Class
90.97‌ 
–‌
–‌
-39.23‌ 
2/22/21
The
fund’s
performance
information
represents
only
past
performance
and
is
not
necessarily
an
indication
of
future
results.
Current
performance
may
be
lower
or
higher
than
the
performance
data
cited.
Share
price,
principal
value,
and
return
will
vary,
and
you
may
have
a
gain
or
loss
when
you
sell
your
shares.
For
the
most
recent
month-end
performance,
please
visit
our
website
(troweprice.com)
or
contact
a
T.
Rowe
Price
representative
at
1
-
800
-
225
-
5132
or,
for
2
I
and
3
Z
Class
shares,
1-800-638-8790
.
This
table
provides
returns
through
the
most
recent
calendar
quarter-end
rather
than
through
the
end
of
the
fund’s
fiscal
period.
It
shows
how
the
fund
would
have
performed
each
year
if
its
actual
(or
cumulative)
returns
for
the
periods
shown
had
been
earned
at
a
constant
rate.
Average
annual
total
return
figures
include
changes
in
principal
value,
reinvested
dividends,
and
capital
gain
distributions.
Returns
do
not
reflect
taxes
that
the
shareholder
may
pay
on
fund
distributions
or
the
redemption
of
fund
shares.
When
assessing
performance,
investors
should
consider
both
short-
and
long-term
returns.
T.
ROWE
PRICE
Emerging
Europe
Fund
Financial
Highlights
15
For
a
share
outstanding
throughout
each
period
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Investor
Class
..
Year
..
..
Ended
.
10/31/23
10/31/22
10/31/21
10/31/20
10/31/19
NET
ASSET
VALUE
Beginning
of
period
$
2
.34‌
$
19
.13‌
$
11
.23‌
$
15
.76‌
$
13
.77‌
Investment
activities
Net
investment
income
(1)(2)
0
.06‌
0
.10‌
0
.25‌
0
.43‌
0
.47‌
Net
realized
and
unrealized
gain/
loss
1
.34‌
(
16
.63‌
)
8
.08‌
(
4
.42‌
)
1
.94‌
Total
from
investment
activities
1
.40‌
(
16
.53‌
)
8
.33‌
(
3
.99‌
)
2
.41‌
Distributions
Net
investment
income
(
0
.06‌
)
(
0
.26‌
)
(
0
.43‌
)
(
0
.50‌
)
(
0
.42‌
)
Net
realized
gain
—‌
—‌
—‌
(
0
.04‌
)
—‌
Total
distributions
(
0
.06‌
)
(
0
.26‌
)
(
0
.43‌
)
(
0
.54‌
)
(
0
.42‌
)
NET
ASSET
VALUE
End
of
period
$
3
.68‌
$
2
.34‌
$
19
.13‌
$
11
.23‌
$
15
.76‌
Ratios/Supplemental
Data
Total
return
(2)(3)
61
.05‌
%
(
87
.57‌
)
%
75
.35‌
%
(
26
.34‌
)
%
18
.08‌
%
Ratios
to
average
net
assets:
(2)
Gross
expenses
before
waivers/
payments
by
Price
Associates
3
.63‌
%
2
.68‌
%
1
.67‌
%
1
.66‌
%
1
.62‌
%
Net
expenses
after
waivers/
payments
by
Price
Associates
1
.58‌
%
1
.42‌
%
1
.41‌
%
1
.41‌
%
1
.42‌
%
Net
investment
income
1
.70‌
%
1
.57‌
%
1
.59‌
%
3
.19‌
%
3
.22‌
%
Portfolio
turnover
rate
50
.9‌
%
65
.8‌
%
46
.0‌
%
31
.9‌
%
37
.5‌
%
Net
assets,
end
of
period
(in
thousands)
$32,913
$23,681
$162,619
$98,750
$149,960
0‌
%
0‌
%
0‌
%
0‌
%
0‌
%
(1)
Per
share
amounts
calculated
using
average
shares
outstanding
method.
(2)
See
Note
6
for
details
of
expense-related
arrangements
with
Price
Associates.
(3)
Total
return
reflects
the
rate
that
an
investor
would
have
earned
on
an
investment
in
the
fund
during
each
period,
assuming
reinvestment
of
all
distributions,
and
payment
of
no
redemption
or
account
fees,
if
applicable.
T.
ROWE
PRICE
Emerging
Europe
Fund
Financial
Highlights
16
For
a
share
outstanding
throughout
each
period
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
I
Class
..
Year
..
..
Ended
.
10/31/23
10/31/22
10/31/21
10/31/20
10/31/19
NET
ASSET
VALUE
Beginning
of
period
$
2
.35‌
$
19
.29‌
$
11
.29‌
$
15
.80‌
$
13
.81‌
Investment
activities
Net
investment
income
(1)(2)
0
.07‌
0
.08‌
0
.32‌
0
.49‌
0
.53‌
Net
realized
and
unrealized
gain/
loss
1
.34‌
(
16
.67‌
)
8
.12‌
(
4
.45‌
)
1
.93‌
Total
from
investment
activities
1
.41‌
(
16
.59‌
)
8
.44‌
(
3
.96‌
)
2
.46‌
Distributions
Net
investment
income
(
0
.11‌
)
(
0
.35‌
)
(
0
.44‌
)
(
0
.51‌
)
(
0
.47‌
)
Net
realized
gain
—‌
—‌
—‌
(
0
.04‌
)
—‌
Total
distributions
(
0
.11‌
)
(
0
.35‌
)
(
0
.44‌
)
(
0
.55‌
)
(
0
.47‌
)
NET
ASSET
VALUE
End
of
period
$
3
.65‌
$
2
.35‌
$
19
.29‌
$
11
.29‌
$
15
.80‌
Ratios/Supplemental
Data
Total
return
(2)(3)
61
.64‌
%
(
87
.56‌
)
%
75
.96‌
%
(
26
.10‌
)
%
18
.47‌
%
Ratios
to
average
net
assets:
(2)
Gross
expenses
before
waivers/
payments
by
Price
Associates
2
.29‌
%
2
.59‌
%
1
.37‌
%
1
.33‌
%
1
.31‌
%
Net
expenses
after
waivers/
payments
by
Price
Associates
1
.26‌
%
1
.11‌
%
1
.08‌
%
1
.09‌
%
1
.09‌
%
Net
investment
income
2
.05‌
%
2
.17‌
%
1
.97‌
%
3
.57‌
%
3
.63‌
%
Portfolio
turnover
rate
50
.9‌
%
65
.8‌
%
46
.0‌
%
31
.9‌
%
37
.5‌
%
Net
assets,
end
of
period
(in
thousands)
$4,818
$3,146
$6,347
$3,284
$5,750
0‌
%
0‌
%
0‌
%
0‌
%
0‌
%
(1)
Per
share
amounts
calculated
using
average
shares
outstanding
method.
(2)
See
Note
6
for
details
of
expense-related
arrangements
with
Price
Associates.
(3)
Total
return
reflects
the
rate
that
an
investor
would
have
earned
on
an
investment
in
the
fund
during
each
period,
assuming
reinvestment
of
all
distributions,
and
payment
of
no
redemption
or
account
fees,
if
applicable.
T.
ROWE
PRICE
Emerging
Europe
Fund
Financial
Highlights
17
For
a
share
outstanding
throughout
each
period
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Z
Class
(1)
..
Year
..
..
Ended
.
2/22/21
(1)
Through
10/31/21
10/31/23
10/31/22
NET
ASSET
VALUE
Beginning
of
period
$
2
.36‌
$
19
.31‌
$
15
.10‌
Investment
activities
Net
investment
income
(2)(3)
0
.10‌
0
.20‌
0
.52‌
Net
realized
and
unrealized
gain/loss
1
.34‌
(
16
.67‌
)
3
.69‌
Total
from
investment
activities
1
.44‌
(
16
.47‌
)
4
.21‌
Distributions
Net
investment
income
(
0
.15‌
)
(
0
.48‌
)
—‌
NET
ASSET
VALUE
End
of
period
$
3
.65‌
$
2
.36‌
$
19
.31‌
Ratios/Supplemental
Data
Total
return
(3)(4)
63
.65‌
%
(
87
.42‌
)
%
27
.88‌
%
Ratios
to
average
net
assets:
(3)
Gross
expenses
before
waivers/payments
by
Price
Associates
2
.25‌
%
1
.81‌
%
1
.41‌
%
(5)
Net
expenses
after
waivers/payments
by
Price
Associates
0
.17‌
%
0
.00‌
%
0
.00‌
%
(5)
Net
investment
income
3
.16‌
%
2
.87‌
%
4
.42‌
%
(5)
Portfolio
turnover
rate
50
.9‌
%
65
.8‌
%
46
.0‌
%
Net
assets,
end
of
period
(in
thousands)
$2,832
$1,735
$14,642
0‌
%
0‌
%
0‌
%
(1)
Inception
date
(2)
Per
share
amounts
calculated
using
average
shares
outstanding
method.
(3)
See
Note
6
for
details
of
expense-related
arrangements
with
Price
Associates.
(4)
Total
return
reflects
the
rate
that
an
investor
would
have
earned
on
an
investment
in
the
fund
during
each
period,
assuming
reinvestment
of
all
distributions,
and
payment
of
no
redemption
or
account
fees,
if
applicable.
Total
return
is
not
annualized
for
periods
less
than
one
year.
(5)
Annualized
T.
ROWE
PRICE
Emerging
Europe
Fund
October
31,
2023
18
Portfolio
of
Investments
Shares
$
Value
(
Cost
and
value
in
$000s)
CYPRUS
0.0%
Common
Stocks
0.0%
Galaxy
Cosmos
Mezz
 (1)
13,255‌
7‌
TCS
Group
Holding,
GDR
(RUB)  (1)(2)
66,273‌
—‌
Total
Cyprus
(Cost
$5,352
)
7‌
GREECE
30.3%
Common
Stocks
30.3%
Alpha
Services
and
Holdings  (1)
357,887‌
536‌
Eurobank
Ergasias
Services
&
Holdings  (1)
1,177,018‌
1,924‌
JUMBO 
43,435‌
1,143‌
LAMDA
Development  (1)
105,474‌
679‌
Motor
Oil
Hellas
Corinth
Refineries 
30,379‌
723‌
National
Bank
of
Greece  (1)
954,280‌
5,465‌
OPAP 
73,605‌
1,247‌
Public
Power  (1)
30,175‌
308‌
Terna
Energy 
17,061‌
256‌
Total
Greece
(Cost
$6,626
)
12,281‌
HUNGARY
11.5%
Common
Stocks
11.5%
OTP
Bank 
92,929‌
3,459‌
Richter
Gedeon
40,682‌
954‌
Wizz
Air
Holdings
(GBP)  (1)
13,902‌
262‌
Total
Hungary
(Cost
$3,603
)
4,675‌
KAZAKHSTAN
6.4%
Common
Stocks
6.4%
Halyk
Savings
Bank
of
Kazakhstan,
GDR
(USD) 
131,376‌
1,644‌
Kaspi.KZ,
GDR
(USD) 
10,589‌
957‌
Kazakhstan
Kagazy
,
GDR
(USD)  (1)(2)(3)(4)
327,395‌
—‌
Total
Kazakhstan
(Cost
$19,074
)
2,601‌
POLAND
12.5%
Common
Stocks
12.5%
Allegro.eu  (1)
102,804‌
737‌
InPost
(EUR) (1)
133,284‌
1,319‌
mBank
 (1)
3,947‌
488‌
T.
ROWE
PRICE
Emerging
Europe
Fund
19
Shares
$
Value
(Cost
and
value
in
$000s)
Powszechna
Kasa
Oszczednosci
Bank
Polski
 (1)
57,532‌
596‌
Powszechny
Zaklad
Ubezpieczen
169,099‌
1,914‌
Total
Poland
(Cost
$5,337
)
5,054‌
PORTUGAL
1.3%
Common
Stocks
1.3%
Jeronimo
Martins 
22,383‌
516‌
Total
Portugal
(Cost
$481
)
516‌
RUSSIA
0.0%
Common
Stocks
0.0%
Gazprom  (1)(2)
3,658,844‌
—‌
LUKOIL  (2)
170,476‌
—‌
Magnit
 (2)
32,681‌
—‌
MMC
Norilsk
Nickel  (1)(2)
21,740‌
—‌
MMC
Norilsk
Nickel,
ADR
(USD)  (1)(2)
15‌
—‌
Moscow
Exchange  (2)
207,430‌
—‌
Novatek
 (2)
230,520‌
—‌
Rosneft
Oil (2)
607,203‌
—‌
Sberbank
of
Russia  (2)
10,373,360‌
—‌
Segezha
Group (1)(2)
11,000,000‌
—‌
Surgutneftegas
 (2)
2,584,700‌
—‌
Yandex
,
Class
A  (1)(2)
69,578‌
—‌
Total
Russia
(Cost
$57,533
)
—‌
TÜRKIYE
32.7%
Common
Stocks
32.7%
BIM
Birlesik
Magazalar
268,633‌
2,583‌
D-MARKET
Elektronik
Hizmetler
ve
Ticaret
,
ADR
(USD)  (1)
2,257,733‌
2,551‌
Eregli
Demir
ve
Celik
Fabrikalari
(1)
772,777‌
1,034‌
KOC
Holding
543,036‌
2,627‌
TAV
Havalimanlari
Holding
(1)
62,388‌
253‌
Turk
Hava
Yollari
AO
(1)
169,801‌
1,304‌
Turkcell
Iletisim
Hizmetleri
(1)
639,128‌
1,084‌
Türkiye
Petrol
Rafinerileri
362,774‌
1,820‌
Total
Türkiye
(Cost
$12,422
)
13,256‌
UNITED
KINGDOM
4.9%
Common
Stocks
4.9%
Baltic
Classifieds
Group 
358,371‌
861‌
T.
ROWE
PRICE
Emerging
Europe
Fund
20
Shares
$
Value
(Cost
and
value
in
$000s)
Central
Asia
Metals 
103,390‌
206‌
Endava
,
ADR
(USD)  (1)(5)
1,058‌
53‌
Georgia
Capital  (1)
79,122‌
887‌
Total
United
Kingdom
(Cost
$1,717
)
2,007‌
SHORT-TERM
INVESTMENTS
0.0%
Money
Market
Funds
0.0%
T.
Rowe
Price
Government
Reserve
Fund,
5.42%  (3)(6)
1,028‌
1‌
Total
Short-Term
Investments
(Cost
$1)
1‌
SECURITIES
LENDING
COLLATERAL
0.1%
INVESTMENTS
IN
A
POOLED
ACCOUNT
THROUGH
SECURITIES
LENDING
PROGRAM
WITH
JPMORGAN
CHASE
BANK
0.1%
Money
Market
Funds
0.1%
T.
Rowe
Price
Government
Reserve
Fund,
5.42%  (3)(6)
40,245‌
40‌
Total
Investments
in
a
Pooled
Account
through
Securities
Lending
Program
with
JPMorgan
Chase
Bank
40‌
Total
Securities
Lending
Collateral
(Cost
$40)
40‌
Total
Investments
in
Securities
99.7%
of
Net
Assets
(Cost
$112,186)
$
40,438‌
Country
classifications
are
generally
based
on
MSCI
categories
or
another
unaffiliated
third
party
data
provider;
Shares
are
denominated
in
the
currency
of
the
country
presented
unless
otherwise
noted.
(1)
Non-income
producing
(2)
See
Note
2.
Level
3
in
fair
value
hierarchy.
(3)
Affiliated
Companies
(4)
Security
was
purchased
pursuant
to
Rule
144A
under
the
Securities
Act
of
1933
and
may
be
resold
in
transactions
exempt
from
registration
only
to
qualified
institutional
buyers.
Total
value
of
such
securities
at
period-end
amounts
to
$0
and
represents
0.0%
of
net
assets.
(5)
See
Note
3
.
All
or
a
portion
of
this
security
is
on
loan
at
October
31,
2023.
(6)
Seven-day
yield
T.
ROWE
PRICE
Emerging
Europe
Fund
21
ADR
American
Depositary
Receipts
EUR
Euro
GBP
British
Pound
GDR
Global
Depositary
Receipts
RUB
Russian
Ruble
USD
U.S.
Dollar
T.
ROWE
PRICE
Emerging
Europe
Fund
22
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
AFFILIATED
COMPANIES
($000s)
The
fund
may
invest
in
certain
securities
that
are
considered
affiliated
companies.
As
defined
by
the
1940
Act,
an
affiliated
company
is
one
in
which
the
fund
owns
5%
or
more
of
the
outstanding
voting
securities,
or
a
company
that
is
under
common
ownership
or
control.
The
following
securities
were
considered
affiliated
companies
for
all
or
some
portion
of
the
year
ended
October
31,
2023.
Net
realized
gain
(loss),
investment
income,
change
in
net
unrealized
gain/loss,
and
purchase
and
sales
cost
reflect
all
activity
for
the
period
then
ended.
Affiliate
Net
Realized
Gain
(Loss)
Change
in
Net
Unrealized
Gain/Loss
Investment
Income
Kazakhstan
Kagazy
,
GDR 
$
—‌
$
—‌
$
—‌
T.
Rowe
Price
Government
Reserve
Fund,
5.42%
—‌
—‌
97‌++
Totals
$
—‌#
$
—‌
$
97‌+
Supplementary
Investment
Schedule
Affiliate
Value
10/31/22
Purchase
Cost
Sales
Cost
Value
10/31/23
Kazakhstan
Kagazy
,
GDR 
$
—‌
$
—‌
$
—‌
$
—‌
T.
Rowe
Price
Government
Reserve
Fund,
5.42%
1,195‌
  ¤
  ¤
41‌
Total
$
41‌^
#
Capital
gain
distributions
from
underlying
Price
funds
represented
$0
of
the
net
realized
gain
(loss).
++
Excludes
earnings
on
securities
lending
collateral,
which
are
subject
to
rebates
and
fees
as
described
in
Note
3
.
+
Investment
income
comprised
$97
of
dividend
income
and
$0
of
interest
income.
¤
Purchase
and
sale
information
not
shown
for
cash
management
funds.
^
The
cost
basis
of
investments
in
affiliated
companies
was
$16,662.
T.
ROWE
PRICE
Emerging
Europe
Fund
October
31,
2023
Statement
of
Assets
and
Liabilities
23
($000s,
except
shares
and
per
share
amounts)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Assets
Investments
in
securities,
at
value
(cost
$112,186)
$
40,438‌
Receivable
for
investment
securities
sold
688‌
Due
from
affiliates
3‌
Receivable
for
shares
sold
2‌
Other
assets
72‌
Total
assets
41,203‌
Liabilities
Payable
for
investment
securities
purchased
293‌
Payable
for
shares
redeemed
69‌
Obligation
to
return
securities
lending
collateral
40‌
Investment
management
fees
payable
37‌
Other
liabilities
201‌
Total
liabilities
640‌
NET
ASSETS
$
40,563‌
Net
Assets
Consist
of:
Total
distributable
earnings
(loss)
$
(
111,149‌
)
Paid-in
capital
applicable
to
11,040,246
shares
of
$0.01
par
value
capital
stock
outstanding;
18,000,000,000
shares
of
the
Corporation
authorized
151,712‌
NET
ASSETS
$
40,563‌
NET
ASSET
VALUE
PER
SHARE
Investor
Class
(Net
assets:
$32,913;
Shares
outstanding:
8,945,078)
$
3.68‌
I
Class
(Net
assets:
$4,818;
Shares
outstanding:
1,320,093)
$
3.65‌
Z
Class
(Net
assets:
$2,832;
Shares
outstanding:
775,075)
$
3.65‌
T.
ROWE
PRICE
Emerging
Europe
Fund
Statement
of
Operations
24
($000s)
Year
Ended
10/31/23
Investment
Income
(Loss)
Income
Dividend
(net
of
foreign
taxes
of
$54)
$
1,290‌
Securities
lending
12‌
Total
income
1,302‌
Expenses
Investment
management
410‌
Shareholder
servicing
Investor
Class
$
399‌
I
Class
2‌
401‌
Prospectus
and
shareholder
reports
Investor
Class
40‌
I
Class
1‌
41‌
Custody
and
accounting
189‌
Depositary
receipt
fees
133‌
Legal
and
audit
88‌
Registration
50‌
Proxy
and
annual
meeting
10‌
Miscellaneous
14‌
Waived
/
paid
by
Price
Associates
(
761‌
)
Total
expenses
575‌
Net
investment
income
727‌
T.
ROWE
PRICE
Emerging
Europe
Fund
Statement
of
Operations
25
($000s)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Year
Ended
10/31/23
Realized
and
Unrealized
Gain
/
Loss
Net
realized
gain
(loss)
Securities
(
18,243‌
)
Foreign
currency
transactions
(
321‌
)
Net
realized
loss
(
18,564‌
)
Change
in
net
unrealized
gain
/
loss
Securities
34,939‌
Other
assets
and
liabilities
denominated
in
foreign
currencies
318‌
Change
in
net
unrealized
gain
/
loss
35,257‌
Net
realized
and
unrealized
gain
/
loss
16,693‌
INCREASE
IN
NET
ASSETS
FROM
OPERATIONS
$
17,420‌
T.
ROWE
PRICE
Emerging
Europe
Fund
Statement
of
Changes
in
Net
Assets
26
($000s)
Year
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
Ended
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
10/31/23
10/31/22
Increase
(Decrease)
in
Net
Assets
Operations
Net
investment
income
$
727‌
$
1,204‌
Net
realized
loss
(
18,564‌
)
(
1,127‌
)
Change
in
net
unrealized
gain
/
loss
35,257‌
(
151,356‌
)
Increase
(decrease)
in
net
assets
from
operations
17,420‌
(
151,279‌
)
Distributions
to
shareholders
Net
earnings
Investor
Class
(
651‌
)
(
2,233‌
)
I
Class
(
138‌
)
(
133‌
)
Z
Class
(
111‌
)
(
359‌
)
Decrease
in
net
assets
from
distributions
(
900‌
)
(
2,725‌
)
Capital
share
transactions
*
Shares
sold
Investor
Class
4,499‌
34,913‌
I
Class
2,083‌
16,373‌
Z
Class
–‌
38‌
Distributions
reinvested
Investor
Class
629‌
2,153‌
I
Class
132‌
133‌
Z
Class
111‌
359‌
Shares
redeemed
Investor
Class
(
9,474‌
)
(
49,417‌
)
I
Class
(
2,492‌
)
(
4,934‌
)
Z
Class
(
7‌
)
(
660‌
)
Decrease
in
net
assets
from
capital
share
transactions
(
4,519‌
)
(
1,042‌
)
T.
ROWE
PRICE
Emerging
Europe
Fund
Statement
of
Changes
in
Net
Assets
27
($000s)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Year
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
Ended
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
10/31/23
10/31/22
Net
Assets
Increase
(decrease)
during
period
12,001‌
(
155,046‌
)
Beginning
of
period
28,562‌
183,608‌
End
of
period
$
40,563‌
$
28,562‌
*Share
information
(000s)
Shares
sold
Investor
Class
1,607‌
7,241‌
I
Class
748‌
2,362‌
Z
Class
–‌
2‌
Distributions
reinvested
Investor
Class
238‌
132‌
I
Class
50‌
8‌
Z
Class
43‌
22‌
Shares
redeemed
Investor
Class
(
3,033‌
)
(
5,739‌
)
I
Class
(
816‌
)
(
1,361‌
)
Z
Class
(
2‌
)
(
48‌
)
Increase
(decrease)
in
shares
outstanding
(
1,165‌
)
2,619‌
T.
ROWE
PRICE
Emerging
Europe
Fund
NOTES
TO
FINANCIAL
STATEMENTS
28
T.
Rowe
Price
International
Funds,
Inc.
(the
corporation) is
registered
under
the
Investment
Company
Act
of
1940
(the
1940
Act).
The
Emerging
Europe
Fund
(the
fund)
is a
nondiversified, open-end
management
investment
company
established
by
the
corporation. The
fund
seeks
long-term
growth
of
capital
through
investments
primarily
in
the
common
stocks
of
companies
located
(or
with
primary
operations)
in
the
emerging
market
countries
of
Europe.
The
fund
has
three classes
of
shares:
the
Emerging
Europe
Fund
(Investor
Class),
the
Emerging
Europe
Fund–I
Class
(I
Class)
and
the
Emerging
Europe
Fund–Z
Class
(Z
Class).
I
Class
shares
require
a
$500,000
initial
investment
minimum,
although
the
minimum
generally
is
waived
or
reduced
for
financial
intermediaries,
eligible
retirement
plans,
and
certain
other
accounts.
Prior
to
November
15,
2021,
the
initial
investment
minimum
was
$1
million
and
was
generally
waived
for
financial
intermediaries,
eligible
retirement
plans,
and
other
certain
accounts.
As
a
result
of
the
reduction
in
the
I
Class
minimum,
certain
assets
transferred
from
the
Investor
Class
to
the
I
Class.
This
transfer
of
shares
from
Investor
Class
to
I
Class
is
reflected
in
the
Statement
of
Changes
in
Net
Assets
within
the
Capital
shares
transactions
as
Shares
redeemed
and
Shares
sold,
respectively.
The
Z
Class
is
only
available
to
funds
advised
by
T.
Rowe
Price
Associates,
Inc.
and
its
affiliates
and
other
clients
that
are
subject
to
a
contractual
fee
for
investment
management
services. Each
class
has
exclusive
voting
rights
on
matters
related
solely
to
that
class;
separate
voting
rights
on
matters
that
relate
to
all classes;
and,
in
all
other
respects,
the
same
rights
and
obligations
as
the
other
classes.
Effective
February
17,
2023,
the
fund
is
closed
to
all
purchases
from
new
and
existing
shareholders.
The
fund’s
closure
to
additional
purchases
does
not
restrict
existing
shareholders
from
redeeming
shares
of
the
fund.
NOTE
1
-
SIGNIFICANT
ACCOUNTING
POLICIES 
Basis
of
Preparation
 The fund
is
an
investment
company
and
follows
accounting
and
reporting
guidance
in
the
Financial
Accounting
Standards
Board
(FASB)
Accounting
Standards
Codification
Topic
946
(ASC
946).
The
accompanying
financial
statements
were
prepared
in
accordance
with
accounting
principles
generally
accepted
in
the
United
States
of
America
(GAAP),
including,
but
not
limited
to,
ASC
946.
GAAP
requires
the
use
of
estimates
made
by
management.
Management
believes
that
estimates
and
valuations
are
appropriate;
however,
actual
results
may
differ
from
those
estimates,
and
the
valuations
reflected
in
the
accompanying
financial
statements
may
differ
from
the
value
ultimately
realized
upon
sale
or
maturity.
T.
ROWE
PRICE
Emerging
Europe
Fund
29
Investment
Transactions,
Investment
Income,
and
Distributions
 Investment
transactions
are
accounted
for
on
the
trade
date
basis.
Income
and
expenses
are
recorded
on
the
accrual
basis.
Realized
gains
and
losses
are
reported
on
the
identified
cost
basis. Income
tax-related
interest
and
penalties,
if
incurred,
are
recorded
as
income
tax
expense. Dividends
received
from other
investment
companies are
reflected
as
dividend
income;
capital
gain
distributions
are
reflected
as
realized
gain/loss. Dividend
income and
capital
gain
distributions
are
recorded
on
the
ex-dividend
date. Non-cash
dividends,
if
any,
are
recorded
at
the
fair
market
value
of
the
asset
received. Proceeds
from
litigation
payments,
if
any,
are
included
in
either
net
realized
gain
(loss)
or
change
in
net
unrealized
gain/loss
from
securities. Distributions
to
shareholders
are
recorded
on
the
ex-dividend
date. Income
distributions,
if
any,
are
declared
and
paid
by
each
class annually. A
capital
gain
distribution,
if
any, may
also
be
declared
and
paid
by
the
fund
annually.
Currency
Translation
 Assets,
including
investments,
and
liabilities
denominated
in
foreign
currencies
are
translated
into
U.S.
dollar
values
each
day
at
the
prevailing
exchange
rate,
using
the
mean
of
the
bid
and
asked
prices
of
such
currencies
against
U.S.
dollars
as
provided
by
an
outside
pricing
service.
Purchases
and
sales
of
securities,
income,
and
expenses
are
translated
into
U.S.
dollars
at
the
prevailing
exchange
rate
on
the
respective
date
of
such
transaction.
The
effect
of
changes
in
foreign
currency
exchange
rates
on
realized
and
unrealized
security
gains
and
losses
is
not
bifurcated
from
the
portion
attributable
to
changes
in
market
prices.
Class
Accounting
 Shareholder
servicing,
prospectus,
and
shareholder
report
expenses
incurred
by
each
class
are
charged
directly
to
the
class
to
which
they
relate.
Expenses
common
to
all
classes,
investment
income,
and
realized
and
unrealized
gains
and
losses
are
allocated
to
the
classes
based
upon
the
relative
daily
net
assets
of
each
class.
Capital
Transactions
 Each
investor’s
interest
in
the
net
assets
of the
fund
is
represented
by
fund
shares. The
fund’s
net
asset
value
(NAV)
per
share
is
computed
at
the
close
of
the
New
York
Stock
Exchange
(NYSE),
normally
4
p.m.
ET,
each
day
the
NYSE
is
open
for
business.
However,
the
NAV
per
share
may
be
calculated
at
a
time
other
than
the
normal
close
of
the
NYSE
if
trading
on
the
NYSE
is
restricted,
if
the
NYSE
closes
earlier,
or
as
may
be
permitted
by
the
SEC.
Purchases
and
redemptions
of
fund
shares
are
transacted
at
the
next-computed
NAV
per
share,
after
receipt
of
the
transaction
order
by
T.
Rowe
Price
Associates,
Inc.,
or
its
agents.
New
Accounting
Guidance
 In
June
2022,
the
FASB
issued
Accounting
Standards
Update
(ASU),
ASU
2022-03,
Fair
Value
Measurement
(Topic
820)
Fair
Value
Measurement
of
Equity
Securities
Subject
to
Contractual
Sale
Restrictions,
which
clarifies
that
a
contractual
restriction
on
the
sale
of
an
equity
security
is
not
considered
T.
ROWE
PRICE
Emerging
Europe
Fund
30
part
of
the
unit
of
account
of
the
equity
security
and,
therefore,
is
not
considered
in
measuring
fair
value.
The
amendments
under
this
ASU
are
effective
for
fiscal
years
beginning
after
December
15,
2023;
however,
the
fund
opted
to
early
adopt,
as
permitted,
effective
December
1,
2022. Adoption
of
the
guidance
did not
have
a
material
impact
on
the fund's
financial  statements.
Indemnification
 In
the
normal
course
of
business, the
fund
may
provide
indemnification
in
connection
with
its
officers
and
directors,
service
providers,
and/or
private
company
investments. The
fund’s
maximum
exposure
under
these
arrangements
is
unknown;
however,
the
risk
of
material
loss
is
currently
considered
to
be
remote.
NOTE
2
-
VALUATION 
Fair
Value
  The
fund’s
financial
instruments
are
valued
at
the
close
of
the
NYSE
and
are
reported
at
fair
value,
which
GAAP
defines
as
the
price
that
would
be
received
to
sell
an
asset
or
paid
to
transfer
a
liability
in
an
orderly
transaction
between
market
participants
at
the
measurement
date. The fund’s
Board
of
Directors
(the
Board)
has
designated
T.
Rowe
Price
Associates,
Inc.
as
the
fund’s
valuation
designee
(Valuation
Designee).
Subject
to
oversight
by
the
Board,
the
Valuation
Designee
performs
the
following
functions
in
performing
fair
value
determinations:
assesses
and
manages
valuation
risks;
establishes
and
applies
fair
value
methodologies;
tests
fair
value
methodologies;
and
evaluates
pricing
vendors
and
pricing
agents.
The
duties
and
responsibilities
of
the
Valuation
Designee
are
performed
by
its
Valuation
Committee. The
Valuation
Designee provides
periodic
reporting
to
the
Board
on
valuation
matters.
Various
valuation
techniques
and
inputs
are
used
to
determine
the
fair
value
of
financial
instruments.
GAAP
establishes
the
following
fair
value
hierarchy
that
categorizes
the
inputs
used
to
measure
fair
value:
Level
1
quoted
prices
(unadjusted)
in
active
markets
for
identical
financial
instruments
that
the
fund
can
access
at
the
reporting
date
Level
2
inputs
other
than
Level
1
quoted
prices
that
are
observable,
either
directly
or
indirectly
(including,
but
not
limited
to,
quoted
prices
for
similar
financial
instruments
in
active
markets,
quoted
prices
for
identical
or
similar
financial
instruments
in
inactive
markets,
interest
rates
and
yield
curves,
implied
volatilities,
and
credit
spreads)
Level
3
unobservable
inputs
(including
the Valuation
Designee’s assumptions
in
determining
fair
value)
T.
ROWE
PRICE
Emerging
Europe
Fund
31
Observable
inputs
are
developed
using
market
data,
such
as
publicly
available
information
about
actual
events
or
transactions,
and
reflect
the
assumptions
that
market
participants
would
use
to
price
the
financial
instrument.
Unobservable
inputs
are
those
for
which
market
data
are
not
available
and
are
developed
using
the
best
information
available
about
the
assumptions
that
market
participants
would
use
to
price
the
financial
instrument.
GAAP
requires
valuation
techniques
to
maximize
the
use
of
relevant
observable
inputs
and
minimize
the
use
of
unobservable
inputs.
When
multiple
inputs
are
used
to
derive
fair
value,
the
financial
instrument
is
assigned
to
the
level
within
the
fair
value
hierarchy
based
on
the
lowest-level
input
that
is
significant
to
the
fair
value
of
the
financial
instrument.
Input
levels
are
not
necessarily
an
indication
of
the
risk
or
liquidity
associated
with
financial
instruments
at
that
level
but
rather
the
degree
of
judgment
used
in
determining
those
values.
Valuation
Techniques 
Equity
securities,
including
exchange-traded
funds, listed
or
regularly
traded
on
a
securities
exchange
or
in
the
over-the-counter
(OTC)
market
are
valued
at
the
last
quoted
sale
price
or,
for
certain
markets,
the
official
closing
price
at
the
time
the
valuations
are
made.
OTC
Bulletin
Board
securities
are
valued
at
the
mean
of
the
closing
bid
and
asked
prices.
A
security
that
is
listed
or
traded
on
more
than
one
exchange
is
valued
at
the
quotation
on
the
exchange
determined
to
be
the
primary
market
for
such
security.
Listed
securities
not
traded
on
a
particular
day
are
valued
at
the
mean
of
the
closing
bid
and
asked
prices
for
domestic
securities
and
the
last
quoted
sale
or
closing
price
for
international
securities.
The
last
quoted
prices
of
non-U.S.
equity
securities
may
be
adjusted
to
reflect
the
fair
value
of
such
securities
at
the
close
of
the
NYSE,
if
the Valuation
Designee
determines
that
developments
between
the
close
of
a
foreign
market
and
the
close
of
the
NYSE
will
affect
the
value
of
some
or
all
of
the fund’s portfolio
securities.
Each
business
day,
the
Valuation
Designee uses
information
from
outside
pricing
services
to
evaluate
the
quoted
prices
of
portfolio
securities
and,
if
appropriate,
decide whether
it
is
necessary
to
adjust
quoted
prices
to
reflect
fair
value
by
reviewing
a
variety
of
factors,
including
developments
in
foreign
markets,
the
performance
of
U.S.
securities
markets,
and
the
performance
of
instruments
trading
in
U.S.
markets
that
represent
foreign
securities
and
baskets
of
foreign
securities. The Valuation
Designee
uses
outside
pricing
services
to
provide
it
with
quoted
prices
and
information
to
evaluate
or
adjust
those
prices.
The Valuation
Designee
cannot
predict
how
often
it
will
use
quoted
prices
and
how
often
it
will
determine
it
necessary
to
adjust
those
prices
to
reflect
fair
value.
Investments
in
mutual
funds
are
valued
at
the
mutual
fund’s
closing
NAV
per
share
on
the
day
of
valuation.
Assets
and
liabilities
other
than
financial
instruments,
including
short-term
receivables
and
payables,
are
carried
at
cost,
or
estimated
realizable
value,
if
less,
which
approximates
fair
value. 
T.
ROWE
PRICE
Emerging
Europe
Fund
32
Investments
for
which
market
quotations are
not
readily
available
or
deemed
unreliable
are
valued
at
fair
value
as
determined
in
good
faith
by
the
Valuation
Designee.
The
Valuation
Designee
has
adopted
methodologies
for
determining
the
fair
value
of
investments
for
which
market
quotations
are
not
readily
available
or
deemed
unreliable,
including
the
use
of
other
pricing
sources.
Factors
used
in
determining
fair
value
vary
by
type
of
investment
and
may
include
market
or
investment
specific
considerations.
The
Valuation
Designee typically
will
afford
greatest
weight
to
actual
prices
in
arm’s
length
transactions,
to
the
extent
they
represent
orderly
transactions
between
market
participants,
transaction
information
can
be
reliably
obtained,
and
prices
are
deemed
representative
of
fair
value.
However,
the
Valuation
Designee may
also
consider
other
valuation
methods
such
as
market-based
valuation
multiples;
a
discount
or
premium
from
market
value
of
a
similar,
freely
traded
security
of
the
same
issuer;
discounted
cash
flows;
yield
to
maturity;
or
some
combination.
Fair
value
determinations
are
reviewed
on
a
regular
basis.
Because
any
fair
value
determination
involves
a
significant
amount
of
judgment,
there
is
a
degree
of
subjectivity
inherent
in
such
pricing
decisions. Fair
value
prices
determined
by
the
Valuation
Designee could
differ
from
those
of
other
market
participants,
and
it
is
possible
that
the
fair
value
determined
for
a
security
may
be
materially
different
from
the
value
that
could
be
realized
upon
the
sale
of
that
security.
Valuation
Inputs
  The
following
table
summarizes
the
fund’s
financial
instruments,
based
on
the
inputs
used
to
determine
their
fair
values
on
October
31,
2023
(for
further
detail
by
category,
please
refer
to
the
accompanying
Portfolio
of
Investments):
NOTE
3
-
OTHER
INVESTMENT
TRANSACTIONS 
Consistent
with
its
investment
objective,
the
fund
engages
in
the
following
practices
to
manage
exposure
to
certain
risks
and/or
to
enhance
performance.
The
investment
objective,
policies,
program,
and
risk
factors
of
the
fund
are
described
more
fully
in
the
fund's
prospectus
and
Statement
of
Additional
Information.
($000s)
Level
1
Level
2
Level
3
Total
Value
Assets
Common
Stocks
$
2,604‌
$
37,793‌
$
—‌
$
40,397‌
Short-Term
Investments
1‌
—‌
—‌
1‌
Securities
Lending
Collateral
40‌
—‌
—‌
40‌
Total
$
2,645‌
$
37,793‌
$
—‌
$
40,438‌
T.
ROWE
PRICE
Emerging
Europe
Fund
33
Emerging
and
Frontier
Markets
 The fund
invests,
either
directly
or
through
investments
in
other
T.
Rowe
Price
funds,
in
securities
of
companies
located
in,
issued
by
governments
of,
or
denominated
in
or
linked
to
the
currencies
of
emerging
and
frontier
market
countries.
Emerging
markets,
and
to
a
greater
extent
frontier
markets, tend
to
have
economic
structures
that
are
less
diverse
and
mature,
less
developed
legal
and
regulatory
regimes,
and
political
systems
that
are
less
stable,
than
those
of
developed
countries.
These
markets
may
be
subject
to
greater
political,
economic,
and
social
uncertainty
and
differing
accounting
standards
and
regulatory
environments
that
may
potentially
impact
the
fund’s
ability
to
buy
or
sell
certain
securities
or
repatriate
proceeds
to
U.S.
dollars.
Emerging
markets
securities
exchanges
are
more
likely
to
experience
delays
with
the
clearing
and
settling
of
trades,
as
well
as
the
custody
of
holdings
by
local
banks,
agents,
and
depositories.
Such
securities
are
often
subject
to
greater
price
volatility,
less
liquidity,
and
higher
rates
of
inflation
than
U.S.
securities.
Investing
in
frontier
markets
is
typically
significantly
riskier
than
investing
in
other
countries,
including
emerging
markets.
In
February
2022,
Russian
forces
entered
Ukraine
and
commenced
an
armed
conflict,
leading
to
economic
sanctions
imposed
on
Russia
that
target certain
of
its
citizens
and
issuers
and
sectors
of
the
Russian
economy,
including
the
exclusion
of
Russia
from
the
SWIFT
global
payments
network.
As
a
result,
the
Russian
central
bank suspended
the
sales
of
Russian
securities
by
non-residents
of
Russia
on
its
local
stock
exchange.
In
addition,
U.S.
and
non-U.S.
exchanges
have
halted
trading
in
certain
ADRs
and
GDRs
of
Russian
companies.
Consequently,
the
Russian
equity
market
has
become
largely
uninvestable
for
foreign
investors,
such
as
the
fund,
and
it
is
uncertain
when
these
restrictions
on
trading
or
transferring
Russian
securities
will
be
reduced
or
eliminated. Prior
to
the
market
events
described
above,
the fund
had
67%
of
its
assets
invested
in Russian
securities.
As
a
result
of
the
market
events
described
above,
the
Russian
securities
that
continue
to
be
held
in
the
fund’s
portfolio
that
cannot
be
sold have
been
valued
effectively
at
zero,
and
related
dividend
income
at
realizable
value
of
zero. In
addition,
the
fund
holds
an
investment,
Sberbank
of
Russia,
that
is
included
on
the
U.S.
Specially
Designated
Nationals
and
Blocked
Persons
(SDN)
list.
T.
Rowe
Price,
as
a
U.S.
company,
is
required
to
report
investments
in
any
company
on
the
SDN
list
to
the
U.S.
Department
of
Treasury’s
Office
of
Foreign
Assets
Control.
As
this
conflict
and
market
events
continue
to
evolve,
there
may
be
additional
impacts
to
the
investments
in
the
fund.
Management
is
actively
monitoring
the
risks
and
financial
impacts
arising
from
these
events.
Restricted
Securities
 The
fund
invests
in
securities
that
are
subject
to
legal
or
contractual
restrictions
on
resale.
Prompt
sale
of
such
securities
at
an
acceptable
price
may
be
difficult
and
may
involve
substantial
delays
and
additional
costs.
T.
ROWE
PRICE
Emerging
Europe
Fund
34
Depositary
Receipts
 The
fund
invests
in
American
Depositary
Receipts
(ADRs),
Global
Depositary
Receipts
(GDRs),
and
other
depository
receipts,
which
are
certificates
issued
by
U.S.
and
international
institutions,
such
as
a
bank
or
trust
company,
that
represent
ownership
of
foreign
securities
held
by
the
issuing
institution.
Depositary
receipts
are
transferable,
trade
on
established
markets,
and
entitle
the
holder
to
all
dividends
paid
by
the
underlying
foreign
security.
Issuing
institutions
generally
charge
a
security
administration
fee. 
Securities
Lending
 The fund
may
lend
its
securities
to
approved
borrowers
to
earn
additional
income.
Its
securities
lending
activities
are
administered
by
a
lending
agent
in
accordance
with
a
securities
lending
agreement.
Security
loans
generally
do
not
have
stated
maturity
dates,
and
the
fund
may
recall
a
security
at
any
time.
The
fund
receives
collateral
in
the
form
of
cash
or
U.S.
government
securities.
Collateral
is
maintained
over
the
life
of
the
loan
in
an
amount
not
less
than
the
value
of
loaned
securities;
any
additional
collateral
required
due
to
changes
in
security
values
is
delivered
to
the
fund
the
next
business
day.
Cash
collateral
is
invested
in
accordance
with
investment
guidelines
approved
by
fund
management.
Additionally,
the
lending
agent
indemnifies
the
fund
against
losses
resulting
from
borrower
default.
Although
risk
is
mitigated
by
the
collateral
and
indemnification,
the
fund
could
experience
a
delay
in
recovering
its
securities
and
a
possible
loss
of
income
or
value
if
the
borrower
fails
to
return
the
securities,
collateral
investments
decline
in
value,
and
the
lending
agent
fails
to
perform.
Securities
lending
revenue
consists
of
earnings
on
invested
collateral
and
borrowing
fees,
net
of
any
rebates
to
the
borrower,
compensation
to
the
lending
agent,
and
other
administrative
costs.
In
accordance
with
GAAP,
investments
made
with
cash
collateral
are
reflected
in
the
accompanying
financial
statements,
but
collateral
received
in
the
form
of
securities
is
not.
At
October
31,
2023,
the
value
of
loaned
securities
was
$40,000;
the
value
of
cash
collateral
and
related
investments
was
$40,000.
Other 
Purchases
and
sales
of
portfolio
securities
other
than
short-term securities
aggregated $18,922,000 and
$22,899,000,
respectively,
for
the
year ended
October
31,
2023.
NOTE
4
-
FEDERAL
INCOME
TAXES
Generally,
no
provision
for
federal
income
taxes
is
required
since
the
fund
intends
to
continue
to
qualify
as
a
regulated
investment
company
under
Subchapter
M
of
the
Internal
Revenue
Code
and
distribute
to
shareholders
all
of
its
taxable
income
and
gains.
Distributions
determined
in
accordance
with
federal
income
tax
regulations
may
differ
in
amount
or
character
from
net
investment
income
and
realized
gains
for
financial
reporting
purposes.
T.
ROWE
PRICE
Emerging
Europe
Fund
35
The fund
files
U.S.
federal,
state,
and
local
tax
returns
as
required. The
fund’s
tax
returns
are
subject
to
examination
by
the
relevant
tax
authorities
until
expiration
of
the
applicable
statute
of
limitations,
which
is
generally
three
years
after
the
filing
of
the
tax
return,
but
which
can
be
extended
to
six
years
in
certain
circumstances.
Tax
returns
for
open
years
have
incorporated
no
uncertain
tax
positions
that
require
a
provision
for
income
taxes.
Capital
accounts
within
the
financial
reporting
records
are
adjusted
for
permanent
book/tax
differences
to
reflect
tax
character
but
are
not
adjusted
for
temporary
differences.
The
permanent
book/tax
adjustments,
if
any,
have
no
impact
on
results
of
operations
or
net
assets.
The
permanent
book/tax
adjustments
relate
primarily
to
the
character
of
net
currency
gains
or
losses.
The
tax
character
of
distributions
paid
for
the
periods
presented
was
as
follows:
At
October
31,
2023,
the
tax-basis
cost
of
investments
(including
derivatives,
if
any)
and
gross
unrealized
appreciation
and
depreciation
were
as
follows:
At
October
31,
2023,
the
tax-basis
components
of
accumulated
net
earnings
(loss)
were
as
follows:
($000s)
October
31,
2023
October
31,
2022
Ordinary
income
(including
short-term
capital
gains,
if
any)
$
900‌
$
2,725‌
($000s)
Cost
of
investments
$
114,628‌
Unrealized
appreciation
$
13,648‌
Unrealized
depreciation
(87,524‌)
Net
unrealized
appreciation
(depreciation)
$
(73,876‌)
($000s)
Undistributed
ordinary
income
$
375‌
Net
unrealized
appreciation
(depreciation)
(73,876‌)
Loss
carryforwards
and
deferrals
(37,648‌)
Total
distributable
earnings
(loss)
$
(111,149‌)
T.
ROWE
PRICE
Emerging
Europe
Fund
36
Temporary
differences
between
book-basis
and
tax-basis
components
of
total
distributable
earnings
(loss)
arise
when
certain
items
of
income,
gain,
or
loss
are
recognized
in
different
periods
for
financial
statement
purposes
versus
for
tax
purposes;
these
differences
will
reverse
in
a
subsequent
reporting
period.
The
temporary
differences
relate
primarily
to
the
deferral
of
losses
from
wash
sales.
The
loss
carryforwards
and
deferrals
primarily
relate
to
capital
loss
carryforwards.
Capital
loss
carryforwards
are
available
indefinitely
to
offset
future
realized
capital
gains.
NOTE
5
-
FOREIGN  TAXES
The
fund
is
subject
to
foreign
income
taxes
imposed
by
certain
countries
in
which
it
invests.
Additionally,
capital
gains
realized
upon
disposition
of
securities
issued
in
or
by
certain
foreign
countries
are
subject
to
capital
gains
tax
imposed
by
those
countries.
All
taxes
are
computed
in
accordance
with
the
applicable
foreign
tax
law,
and,
to
the
extent
permitted,
capital
losses
are
used
to
offset
capital
gains.
Taxes
attributable
to
income
are
accrued
by
the
fund
as
a
reduction
of
income.
Current
and
deferred
tax
expense
attributable
to
capital
gains
is
reflected
as
a
component
of
realized
or
change
in
unrealized
gain/loss
on
securities
in
the
accompanying
financial
statements.
To
the
extent
that
the
fund
has
country
specific
capital
loss
carryforwards,
such
carryforwards
are
applied
against
net
unrealized
gains
when
determining
the
deferred
tax
liability.
Any
deferred
tax
liability
incurred
by
the
fund
is
included
in
either
Other
liabilities
or
Deferred
tax
liability
on
the
accompanying
Statement
of
Assets
and
Liabilities.
NOTE
6
-
RELATED
PARTY
TRANSACTIONS
The
fund
is
managed
by
T.
Rowe
Price
Associates,
Inc.
(Price
Associates),
a
wholly
owned
subsidiary
of
T.
Rowe
Price
Group,
Inc.
(Price
Group). Price
Associates
has
entered
into
a
sub-advisory
agreement(s)
with
one
or
more
of
its
wholly
owned
subsidiaries,
to
provide
investment
advisory
services
to
the
fund.
The
investment
management
agreement
between
the
fund
and
Price
Associates
provides
for
an
annual
investment
management
fee,
which
is
computed
daily
and
paid
monthly. The
fee
consists
of
an
individual
fund
fee,
equal
to
0.75%
of
the
fund’s
average
daily
net
assets,
and
a
group
fee.
The
group
fee
rate
is
calculated
based
on
the
combined
net
assets
of
certain
mutual
funds
sponsored
by
Price
Associates
(the
group)
applied
to
a
graduated
fee
schedule,
with
rates
ranging
from
0.48%
for
the
first
$1
billion
of
assets
to
0.260%
for
assets
in
excess
of
$845
billion.
The
fund’s
group
fee
is
determined
by
applying
the
group
fee
rate
to
the
fund’s
average
daily
net
assets. At
October
31,
2023,
the
effective
annual
group
fee
rate
was
0.29%.
T.
ROWE
PRICE
Emerging
Europe
Fund
37
The Investor Class is
subject
to
a
contractual
expense
limitation
through
the
expense
limitation
date
indicated
in
the
table
below.
During
the
limitation
period,
Price
Associates
is required
to
waive
its
management
fee
or
pay
any
expenses
(excluding
interest;
expenses
related
to
borrowings,
taxes,
and
brokerage;
non-recurring,
extraordinary expenses;
and
acquired
fund
fees
and
expenses) that
would
otherwise
cause
the
class’s
ratio
of
annualized
total
expenses
to
average
net
assets
(net
expense
ratio)
to
exceed
its
expense
limitation.
The
class
is
required
to
repay
Price
Associates
for
expenses
previously
waived/paid
to
the
extent
the
class’s
net
assets
grow
or
expenses
decline
sufficiently
to
allow
repayment
without
causing
the
class’s
net
expense
ratio
(after
the
repayment
is
taken
into
account)
to
exceed
the
lesser
of:
(1)
the
expense
limitation
in
place
at
the
time
such
amounts
were
waived;
or
(2)
the
class’s
current
expense
limitation.
However,
no
repayment
will
be
made
more
than
three
years
after
the
date
of
a
payment
or
waiver.
The
I
Class
is
also
subject
to
an
operating
expense
limitation
(I
Class
Limit)
pursuant
to
which
Price
Associates
is
contractually
required
to
pay
all
operating
expenses
of
the
I
Class,
excluding
management
fees;
interest;
expenses
related
to
borrowings,
taxes,
and
brokerage; non-recurring,
extraordinary expenses; and
acquired
fund
fees
and
expenses, to
the
extent
such
operating
expenses,
on
an
annualized
basis,
exceed
the
I
Class
Limit. This
agreement
will
continue
through
the
expense
limitation
date
indicated
in
the
table
below,
and
may
be
renewed,
revised,
or
revoked
only
with
approval
of
the
fund’s
Board.
The
I
Class
is
required
to
repay
Price
Associates
for
expenses
previously
paid
to
the
extent
the
class’s
net
assets
grow
or
expenses
decline
sufficiently
to
allow
repayment
without
causing
the
class’s
operating
expenses
(after
the
repayment
is
taken
into
account)
to
exceed
the
lesser
of:
(1)
the
I
Class
Limit
in
place
at
the
time
such
amounts
were
paid;
or
(2)
the
current
I
Class
Limit.
However,
no
repayment
will
be
made
more
than
three
years
after
the
date
of
a
payment
or
waiver.
The
Z
Class
is
also
subject
to
a
contractual
expense
limitation
agreement
whereby
Price
Associates
has
agreed
to
waive
and/or
bear
all
of
the
Z
Class’
expenses
(excluding
interest;
expenses
related
to
borrowings,
taxes,
and
brokerage;
non-recurring,
extraordinary
expenses;
and
acquired
fund
fees
and
expenses)
in
their
entirety.
This
fee
waiver
and/or
expense
reimbursement
arrangement
is
expected
to
remain
in
place
indefinitely,
and
the
agreement
may
only
be
amended
or
terminated
with
approval
by
the
fund’s
Board.
Expenses
of
the
fund
waived/paid
by
the
manager
are
not
subject
to
later
repayment
by
the
fund.
Pursuant
to
these
agreements,
expenses
were
waived/paid
by
and/or
repaid
to
Price
Associates
during
the
year ended October
31,
2023
as
indicated
in
the
table
below.
Including these
amounts,
expenses
previously
waived/paid
by
Price
Associates
in
the
amount
of $1,813,000 remain
subject
to
repayment
by
the
fund
at
October
31,
2023.
Any
T.
ROWE
PRICE
Emerging
Europe
Fund
38
repayment
of
expenses
previously
waived/paid
by
Price
Associates
during
the
period
would
be
included
in
the
net
investment
income
and
expense
ratios
presented
on
the
accompanying
Financial
Highlights.
In
addition,
the
fund
has
entered
into
service
agreements
with
Price
Associates
and
two
wholly
owned
subsidiaries
of
Price
Associates,
each
an
affiliate
of
the
fund
(collectively,
Price).
Price
Associates
provides
certain
accounting
and
administrative
services
to
the
fund.
T.
Rowe
Price
Services,
Inc.
provides
shareholder
and
administrative
services
in
its
capacity
as
the
fund’s
transfer
and
dividend-disbursing
agent.
T.
Rowe
Price
Retirement
Plan
Services,
Inc.
provides
subaccounting
and
recordkeeping
services
for
certain
retirement
accounts
invested
in
the
Investor
Class.
For
the
year
ended
October
31,
2023,
expenses
incurred
pursuant
to
these
service
agreements
were
$112,000
for
Price
Associates;
$352,000
for
T.
Rowe
Price
Services,
Inc.;
and
$4,000
for
T.
Rowe
Price
Retirement
Plan
Services,
Inc.
All
amounts
due
to
and
due
from
Price,
exclusive
of
investment
management
fees
payable,
are
presented
net
on
the
accompanying
Statement
of
Assets
and
Liabilities.
T.
Rowe
Price
Investment
Services,
Inc.
(Investment
Services)
serves
as
distributor
to
the
fund.
Pursuant
to
an
underwriting
agreement,
no
compensation
for
any
distribution
services
provided
is
paid
to
Investment
Services
by
the
fund
(except
for
12b-1
fees
under
a
Board-approved
Rule
12b-1
plan).  
Mutual
funds,
trusts,
and
other
accounts
managed
by
Price
Associates
or
its
affiliates
(collectively,
Price
Funds
and
accounts)
may
invest
in
the
fund.
No
Price
fund
or
account
may
invest
for
the
purpose
of
exercising
management
or
control
over
the
fund.
At
October
31,
2023, 100%
of
the
Z
Class's
outstanding
shares
were
held
by
Price
Funds
and
accounts.
The fund
may
invest
its
cash
reserves
in
certain
open-end
management
investment
companies
managed
by
Price
Associates
and
considered
affiliates
of
the
fund:
the
T.
Rowe
Price
Government
Reserve
Fund
or
the
T.
Rowe
Price
Treasury
Reserve
Fund,
organized
as
money
market
funds
(together,
the
Price
Reserve
Funds).
The
Price
Reserve
Funds
are
offered
as
short-term
investment
options
to
mutual
funds,
trusts,
and
other
accounts
managed
by
Price
Associates
or
its
affiliates
and
are
not
available
for
direct
Investor
Class
I
Class
Z
Class
Expense
limitation/I
Class
Limit
1.41%
0.05%
0.00%
Expense
limitation
date
02/28/26
02/28/26
N/A
(Waived)/repaid
during
the
period
($000s)
$(659)
$(50)
$(52)
T.
ROWE
PRICE
Emerging
Europe
Fund
39
purchase
by
members
of
the
public.
Cash
collateral
from
securities
lending,
if
any,
is
invested
in
the
T.
Rowe
Price
Government
Reserve Fund. The
Price
Reserve
Funds
pay
no
investment
management
fees.
The
fund may
participate
in
securities
purchase
and
sale
transactions
with
other
funds
or
accounts
advised
by
Price
Associates
(cross
trades),
in
accordance
with
procedures
adopted
by the
fund’s
Board
and
Securities
and
Exchange
Commission
rules,
which
require,
among
other
things,
that
such
purchase
and
sale
cross
trades
be
effected
at
the
independent
current
market
price
of
the
security.
During
the
year
ended
October
31,
2023,
the
fund
had
no
purchases
or
sales
cross
trades
with
other
funds
or
accounts
advised
by
Price
Associates.
NOTE
7
-
OTHER
MATTERS
Unpredictable
events
such
as
environmental
or
natural
disasters,
war
and
conflict,
terrorism,
geopolitical
events,
and
public
health
epidemics and
similar
public
health
threats
may
significantly
affect
the
economy
and
the
markets
and
issuers
in
which
the fund
invests.
Certain
events
may
cause
instability
across
global
markets,
including
reduced
liquidity
and
disruptions
in
trading
markets,
while
some
events
may
affect
certain
geographic
regions,
countries,
sectors,
and
industries
more
significantly
than
others,
and
exacerbate
other
pre-existing
political,
social,
and
economic
risks.
The
global
outbreak
of
COVID-19
and
the
related
governmental
and
public
responses
have
led
and
may
continue
to
lead
to
increased
market
volatility
and
the
potential
for
illiquidity
in
certain
classes
of
securities
and
sectors
of
the
market
either
in
specific
countries
or
worldwide.
In
February
2022,
Russian
forces
entered
Ukraine
and
commenced
an
armed
conflict,
leading
to
economic
sanctions imposed
on
Russia
that
target certain
of
its
citizens
and
issuers
and
sectors
of
the
Russian
economy,
creating
impacts
on
Russian-related
stocks
and
debt
and
greater
volatility
in
global
markets.
In
March
2023,
the
banking
industry
experienced
heightened
volatility,
which
sparked
concerns
of
potential
broader
adverse
market
conditions.
The
extent
of
impact
of
these
events
on
the
US
and
global
markets
is
highly
uncertain.
These
are
recent
examples
of
global
events
which
may
have
a
negative
impact
on
the
values
of
certain
portfolio
holdings
or
the
fund’s
overall
performance.
Management
is
actively
monitoring
the
risks
and
financial
impacts
arising
from
these
events.
T.
ROWE
PRICE
Emerging
Europe
Fund
40
REPORT
OF
INDEPENDENT
REGISTERED
PUBLIC
ACCOUNTING
FIRM
To
the
Board
of
Directors
of
T.
Rowe
Price
International
Funds,
Inc.
and
Shareholders
of
T.
Rowe
Price
Emerging
Europe
Fund
Opinion
on
the
Financial
Statements
We
have
audited
the
accompanying
statement
of
assets
and
liabilities,
including
the
portfolio
of
investments,
of
T.
Rowe
Price
Emerging
Europe
Fund
(one
of
the
funds
constituting
T.
Rowe
Price
International
Funds,
Inc.,
referred
to
hereafter
as
the
"Fund")
as
of
October
31,
2023,
the
related
statement
of
operations
for
the
year
ended
October
31,
2023,
the
statement
of
changes
in
net
assets
for
each
of
the
two
years
in
the
period
ended
October
31,
2023,
including
the
related
notes,
and
the
financial
highlights
for
each
of
the
periods
indicated
therein
(collectively
referred
to
as
the
“financial
statements”).
In
our
opinion,
the
financial
statements
present
fairly,
in
all
material
respects,
the
financial
position
of
the
Fund
as
of
October
31,
2023,
the
results
of
its
operations
for
the
year
then
ended,
the
changes
in
its
net
assets
for
each
of
the
two
years
in
the
period
ended
October
31,
2023
and
the
financial
highlights
for
each
of
the
periods
indicated
therein,
in
conformity
with
accounting
principles
generally
accepted
in
the
United
States
of
America.
Basis
for
Opinion
These
financial
statements
are
the
responsibility
of
the
Fund’s
management.
Our
responsibility
is
to
express
an
opinion
on
the
Fund’s
financial
statements
based
on
our
audits.
We
are
a
public
accounting
firm
registered
with
the
Public
Company
Accounting
Oversight
Board
(United
States)
(PCAOB)
and
are
required
to
be
independent
with
respect
to
the
Fund
in
accordance
with
the
U.S.
federal
securities
laws
and
the
applicable
rules
and
regulations
of
the
Securities
and
Exchange
Commission
and
the
PCAOB.
We
conducted
our
audits
of
these
financial
statements
in
accordance
with
the
standards
of
the
PCAOB.
Those
standards
require
that
we
plan
and
perform
the
audit
to
obtain
reasonable
assurance
about
whether
the
financial
statements
are
free
of
material
misstatement,
whether
due
to
error
or
fraud.
Our
audits
included
performing
procedures
to
assess
the
risks
of
material
misstatement
of
the
financial
statements,
whether
due
to
error
or
fraud,
and
performing
procedures
that
respond
to
those
risks.
Such
procedures
included
examining,
on
a
test
basis,
evidence
regarding
the
amounts
and
disclosures
in
the
financial
statements.
Our
audits
also
included
evaluating
the
accounting
principles
used
and
significant
estimates
made
by
management,
as
well
as
evaluating
the
overall
presentation
of
the
financial
statements.
Our
procedures
included
confirmation
of
securities
owned
as
of
October
31,
2023
by
T.
ROWE
PRICE
Emerging
Europe
Fund
41
correspondence
with
the
custodian,
transfer
agent
and
brokers;
when
replies
were
not
received
from
brokers,
we
performed
other
auditing
procedures.
We
believe
that
our
audits
provide
a
reasonable
basis
for
our
opinion.
/s/
PricewaterhouseCoopers
LLP
Baltimore,
Maryland
December
19,
2023
We
have
served
as
the
auditor
of
one
or
more
investment
companies
in
the
T.
Rowe
Price
group
of
investment
companies
since
1973.
REPORT
OF
INDEPENDENT
REGISTERED
PUBLIC
ACCOUNTING
FIRM
(continued)
T.
ROWE
PRICE
Emerging
Europe
Fund
42
TAX
INFORMATION
(UNAUDITED)
FOR
THE
TAX
YEAR
ENDED 10/31/23
We
are
providing
this
information
as
required
by
the
Internal
Revenue
Code.
The
amounts
shown
may
differ
from
those
elsewhere
in
this
report
because
of
differences
between
tax
and
financial
reporting
requirements.
For
taxable
non-corporate
shareholders,
$1,263,000 of
the
fund's
income
represents
qualified
dividend
income
subject
to
a
long-term
capital
gains
tax
rate
of
not
greater
than
20%.
The
fund
will
pass
through
foreign
source
income
of
$676,000
and
foreign
taxes
paid
of
$37,000.  
T.
ROWE
PRICE
Emerging
Europe
Fund
43
INFORMATION
ON
PROXY
VOTING
POLICIES,
PROCEDURES,
AND
RECORDS
A
description
of
the
policies
and
procedures
used
by
T.
Rowe
Price
funds
to
determine
how
to
vote
proxies
relating
to
portfolio
securities
is
available
in
each
fund’s
Statement
of
Additional
Information.
You
may
request
this
document
by
calling
1-800-225-5132
or
by
accessing
the
SEC’s
website,
sec.gov.
The
description
of
our
proxy
voting
policies
and
procedures
is
also
available
on
our
corporate
website.
To
access
it,
please
visit
the
following
Web
page:
https://www.troweprice.com/corporate/us/en/utility/policies.html
Scroll
down
to
the
section
near
the
bottom
of
the
page
that
says,
“Proxy
Voting
Guidelines.”
Click
on
the
links
in
the
shaded
box.
Each
fund’s
most
recent
annual
proxy
voting
record
is
available
on
our
website
and
through
the
SEC’s
website.
To
access
it
through
T.
Rowe
Price,
visit
the
website
location
shown
above,
and
scroll
down
to
the
section
near
the
bottom
of
the
page
that
says,
“Proxy
Voting
Records.”
Click
on
the
Proxy
Voting
Records
link
in
the
shaded
box.
RESULTS
OF
PROXY
VOTING
A
Special
Meeting
of
Shareholders
was
held
on
July
24,
2023
for
shareholders
of
record
on
April
7,
2023,
to
elect
the
following
director-nominees
to
serve
on
the
Board
of
all
Price
Funds.
The
newly
elected
Directors
took
office
effective
July
24,
2023.
The
results
of
the
voting
were
as
follows:
Teresa
Bryce
Bazemore,
Bruce
W.
Duncan,
Robert
J.
Gerrard,
Jr.,
Paul
F.
McBride
and
David
Oestreicher
continue
to
serve
as
Directors
on
the
Board
of
all
Price
Funds.
HOW
TO
OBTAIN
QUARTERLY
PORTFOLIO
HOLDINGS
The
fund
files
a
complete
schedule
of
portfolio
holdings
with
the
Securities
and
Exchange
Commission
(SEC)
for
the
first
and
third
quarters
of
each
fiscal
year
as
an
exhibit
to
its
reports
on
Form
N-PORT.
The
fund’s
reports
on
Form
N-PORT
are
available
electronically
on
the
SEC’s
website
(sec.gov).
In
addition,
most
T.
Rowe
Price
funds
disclose
their
first
and
third
fiscal
quarter-end
holdings
on
troweprice.com
.
Votes
For
Votes
Withheld
Melody
Bianchetto
5,316,532,865
42,338,636
Mark
J.
Parrell
5,314,462,793
44,388,756
Kellye
L.
Walker
5,314,203,135
44,903,088
Eric
L.
Veiel
5,309,419,858
49,685,657
T.
ROWE
PRICE
Emerging
Europe
Fund
44
TAILORED
SHAREHOLDER
REPORTS
FOR
MUTUAL
FUNDS
AND
EXCHANGE
TRADED
FUNDS
In
October
2022,
the
Securities
and
Exchange
Commission
(SEC)
adopted
rule
and
form
amendments
requiring
Mutual
Funds
and
Exchange-Traded
Funds
to
transmit
concise
and
visually
engaging
streamlined
annual
and
semiannual
reports
that
highlight
key
information
to
shareholders.
Other
information,
including
financial
statements,
will
no
longer
appear
in
the
funds’
shareholder
reports
but
will
be
available
online,
delivered
free
of
charge
upon
request,
and
filed
on
a
semiannual
basis
on
Form
N-CSR.
The
rule
and
form
amendments
have
a
compliance
date
of
July
24,
2024.
T.
ROWE
PRICE
Emerging
Europe
Fund
45
LIQUIDITY
RISK
MANAGEMENT
PROGRAM
In accordance
with
Rule
22e-4
(Liquidity
Rule)
under
the
Investment
Company
Act
of
1940,
as
amended,
the
fund
has
established
a
liquidity
risk
management
program
(Liquidity
Program)
reasonably
designed
to
assess
and
manage
the
fund’s
liquidity
risk,
which
generally
represents
the
risk
that
the
fund
would
not
be
able
to
meet
redemption
requests
without
significant
dilution
of
remaining
investors’
interests
in
the
fund.
The
fund’s
Board
of
Directors
(Board)
has
appointed
the
fund’s
investment
adviser,
T.
Rowe
Price
Associates,
Inc.
(Adviser),
as
the
administrator
of
the
Liquidity
Program.
As
administrator,
the
Adviser
is
responsible
for
overseeing
the
day-to-day
operations
of
the
Liquidity
Program
and,
among
other
things,
is
responsible
for
assessing,
managing,
and
reviewing
with
the
Board
at
least
annually
the
liquidity
risk
of
each
T.
Rowe
Price
fund.
The
Adviser
has
delegated
oversight
of
the
Liquidity
Program
to
a
Liquidity
Risk
Committee
(LRC),
which
is
a
cross-functional
committee
composed
of
personnel
from
multiple
departments
within
the
Adviser.
The
Liquidity
Program’s
principal
objectives
include
supporting
the
T.
Rowe
Price
funds’
compliance
with
limits
on
investments
in
illiquid
assets
and
mitigating
the
risk
that
the
fund
will
be
unable
to
timely
meet
its
redemption
obligations.
The
Liquidity
Program
also
includes
a
number
of
elements
that
support
the
management
and
assessment
of
liquidity
risk,
including
an
annual
assessment
of
factors
that
influence
the
fund’s
liquidity
and
the
periodic
classification
and
reclassification
of
a
fund’s
investments
into
categories
that
reflect
the
LRC’s
assessment
of
their
relative
liquidity
under
current
market
conditions.
Under
the
Liquidity
Program,
every
investment
held
by
the
fund
is
classified
at
least
monthly
into
one
of
four
liquidity
categories
based
on
estimations
of
the
investment’s
ability
to
be
sold
during
designated
time
frames
in
current
market
conditions
without
significantly
changing
the
investment’s
market
value.
As
required
by
the
Liquidity
Rule,
at
a
meeting
held
on
July
24,
2023,
the
Board
was
presented
with
an
annual
assessment
that
was
prepared
by
the
LRC
on
behalf
of
the
Adviser
and
addressed
the
operation
of
the
Liquidity
Program
and
assessed
its
adequacy
and
effectiveness
of
implementation,
including
any
material
changes
to
the
Liquidity
Program
and
the
determination
of
each
fund’s
Highly
Liquid
Investment
Minimum
(HLIM).
The
annual
assessment
included
consideration
of
the
following
factors,
as
applicable:
the
fund’s
investment
strategy
and
liquidity
of
portfolio
investments
during
normal
and
reasonably
foreseeable
stressed
conditions,
including
whether
the
investment
strategy
is
appropriate
for
an
open-end
fund,
the
extent
to
which
the
strategy
involves
a
relatively
concentrated
portfolio
or
large
positions
in
particular
issuers,
and
the
use
of
borrowings
for
investment
purposes
and
derivatives;
short-term
and
long-term
cash
flow
projections
covering
both
normal
and
reasonably
foreseeable
stressed
conditions;
and
holdings
of
cash
and
cash
equivalents,
as
well
as
available
borrowing
arrangements.
T.
ROWE
PRICE
Emerging
Europe
Fund
46
For the
fund
and
other
T.
Rowe
Price
funds,
the
annual
assessment
incorporated
a
report
related
to
a
fund’s
holdings,
shareholder
and
portfolio
concentration,
any
borrowings
during
the
period,
cash
flow
projections,
and
other
relevant
data
for
the
period
of
April
1,
2022,
through
March
31,
2023.
The
report
described
the
methodology
for
classifying
a
fund’s
investments
(including
any
derivative
transactions)
into
one
of
four
liquidity
categories,
as
well
as
the
percentage
of
a
fund’s
investments
assigned
to
each
category.
It
also
explained
the
methodology
for
establishing
a
fund’s
HLIM
and
noted
that
the
LRC
reviews
the
HLIM
assigned
to
each
fund
no
less
frequently
than
annually.
The
LRC
stated
that
the
fund
was
receiving
increased
monitoring
of
its
overall
liquidity
and
senior
management
attention
due
to
the
impact
of
the
Russia-Ukraine
conflict
on
certain
assets
held
by
the
fund.
During
the
period
covered
by
the
annual
assessment,
the
LRC
has
concluded,
and
reported
to
the
Board,
that
the
Liquidity
Program
continues
to
operate
adequately
and
effectively
and
is
reasonably
designed
to
assess
and
manage
the
fund’s
liquidity
risk.
LIQUIDITY
RISK
MANAGEMENT
PROGRAM
(continued)
T.
ROWE
PRICE
Emerging
Europe
Fund
47
ABOUT
THE
FUND'S
DIRECTORS
AND
OFFICERS
Your
fund
is
overseen
by
a
Board
of
Directors
(Board)
that
meets
regularly
to
review
a
wide
variety
of
matters
affecting
or
potentially
affecting
the
fund,
including
performance,
investment
programs,
compliance
matters,
advisory
fees
and
expenses,
service
providers,
and
business
and
regulatory
affairs.
The
Board
elects
the
fund’s
officers,
who
are
listed
in
the
final
table.
The
directors
who
are
also
employees
or
officers
of
T.
Rowe
Price
are
considered
to
be
“interested”
directors
as
defined
in
Section
2(a)(19)
of
the
1940
Act
because
of
their
relationships
with
T.
Rowe
Price
Associates,
Inc. (T.
Rowe
Price),
and
its
affiliates.
The
business
address
of
each
director
and
officer
is
100
East
Pratt
Street,
Baltimore,
Maryland
21202.
The
Statement
of
Additional
Information
includes
additional
information
about
the
fund
directors
and
is
available
without
charge
by
calling
a
T.
Rowe
Price
representative
at
1-800-638-5660.
INDEPENDENT
DIRECTORS
(a)
Name
(Year
of
Birth)
Year
Elected
[Number
of
T.
Rowe
Price
Portfolios
Overseen]
Principal
Occupation(s)
and
Directorships
of
Public
Companies
and
Other
Investment
Companies
During
the
Past
Five
Years
Teresa
Bryce
Bazemore
(1959)
2018
[209]
President
and
Chief
Executive
Officer,
Federal
Home
Loan
Bank
of
San
Francisco
(2021
to
present);
Chief
Executive
Officer,
Bazemore
Consulting
LLC
(2018
to
2021);
Director,
Chimera
Investment
Corporation
(2017
to
2021);
Director,
First
Industrial
Realty
Trust
(2020
to
present);
Director,
Federal
Home
Loan
Bank
of
Pittsburgh
(2017
to
2019)
Melody
Bianchetto
(1966)
2023
[209]
Vice
President
for
Finance,
University
of
Virginia
(2015
to
2023)
Bruce
W.
Duncan
(1951)
2013
[209]
President,
Chief
Executive
Officer,
and
Director,
CyrusOne,
Inc.
(2020
to
2021);
Chair
of
the
Board
(2016
to
2020)
and
President
(2009
to
2016),
First
Industrial
Realty
Trust,
owner
and
operator
of
industrial
properties;
Member,
Investment
Company
Institute
Board
of
Governors
(2017
to
2019);
Member,
Independent
Directors
Council
Governing
Board
(2017
to
2019);
Senior
Advisor,
KKR
(2018
to
2022);
Director,
Boston
Properties
(2016
to
present);
Director,
Marriott
International,
Inc.
(2016
to
2020)
Robert
J.
Gerrard,
Jr.
(1952)
2012
[209]
Chair
of
the
Board,
all
funds
(July
2018
to
present)
Paul
F.
McBride
(1956)
2013
[209]
Advisory
Board
Member,
Vizzia
Technologies
(2015
to
present);
Board
Member,
Dunbar
Armored
(2012
to
2018)
T.
ROWE
PRICE
Emerging
Europe
Fund
48
INTERESTED  DIRECTORS
(a)
Name
(Year
of
Birth)
Year
Elected
[Number
of
T.
Rowe
Price
Portfolios
Overseen]
Principal
Occupation(s)
and
Directorships
of
Public
Companies
and
Other
Investment
Companies
During
the
Past
Five
Years
Mark
J.
Parrell
(1966)
2023
[209]
Board
of
Trustees
Member
and
Chief
Executive
Officer
(2019
to
present),
President
(2018
to
present),
Executive
Vice
President
and
Chief
Financial
Officer
(2007
to
2018),
and
Senior
Vice
President
and
Treasurer
(2005
to
2007),
EQR;
Member,
Nareit
Dividends
Through
Diversity,
Equity
&
Inclusion
CEO
Council
and
Chair,
Nareit
2021
Audit
and
Investment
Committee
(2021);
Advisory
Board,
Ross
Business
School
at
University
of
Michigan
(2015
to
2016);
Member,
National
Multifamily
Housing
Council
and
served
as
Chair
of
the
Finance
Committee
(2015
to
2016);
Member,
Economic
Club
of
Chicago;
Director,
Brookdale
Senior
Living,
Inc.
(2015
to
2017);
Director,
Aviv
REIT,
Inc.
(2013
to
2015);
Director,
Real
Estate
Roundtable
and
the
2022
Executive
Board
Nareit;
Board
of
Directors
and
Chair
of
the
Finance
Committee,
Greater
Chicago
Food
Depository
Kellye
L.
Walker
(1966)
2021
[209]
Executive
Vice
President
and
Chief
Legal
Officer,
Eastman
Chemical
Company
(April
2020
to
present);
Executive
Vice
President
and
Chief
Legal
Officer,
Huntington
Ingalls
Industries,
Inc.
(January
2015
to
March
2020);
Director,
Lincoln
Electric
Company
(October
2020
to
present)
(a)
All
information
about
the
independent
directors
was
current
as
of
December
31,
2022,
unless
otherwise
indicated,
except
for
the
number
of
portfolios
overseen,
which
is
current
as
of
the
date
of
this
report.
Name
(Year
of
Birth)
Year
Elected
[Number
of
T.
Rowe
Price
Portfolios
Overseen]
Principal
Occupation(s)
and
Directorships
of
Public
Companies
and
Other
Investment
Companies
During
the
Past
Five
Years
David
Oestreicher
(1967)
2018
[209]
Director,
Vice
President,
and
Secretary,
T.
Rowe
Price,
T.
Rowe
Price
Investment
Services,
Inc.,
T.
Rowe
Price
Retirement
Plan
Services,
Inc.,
and
T.
Rowe
Price
Services,
Inc.;
Director
and
Secretary,
T.
Rowe
Price
Investment
Management,
Inc.
(Price
Investment
Management);
Vice
President
and
Secretary,
T.
Rowe
Price
International
(Price
International);
Vice
President,
T.
Rowe
Price
Hong
Kong
(Price
Hong
Kong),
T. Rowe
Price
Japan
(Price
Japan),
and
T.
Rowe
Price
Singapore
(Price
Singapore);
General
Counsel,
Vice
President,
and
Secretary,
T.
Rowe
Price
Group,
Inc.;
Chair
of
the
Board,
Chief
Executive
Officer,
President,
and
Secretary,
T.
Rowe
Price
Trust
Company;
Principal
Executive
Officer
and
Executive
Vice
President,
all
funds
INDEPENDENT
DIRECTORS
(a)
(CONTINUED)
T.
ROWE
PRICE
Emerging
Europe
Fund
49
OFFICERS
Name
(Year
of
Birth)
Year
Elected
[Number
of
T.
Rowe
Price
Portfolios
Overseen]
Principal
Occupation(s)
and
Directorships
of
Public
Companies
and
Other
Investment
Companies
During
the
Past
Five
Years
Eric
L.
Veiel,
CFA
(1972)
2022
[209]
Director
and
Vice
President,
T.
Rowe
Price;
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
T.
Rowe
Price
Trust
Company;
Vice
President,
Global
Funds
(a)
All
information
about
the
interested
directors
was
current
as
of
December
31,
2022,
unless
otherwise
indicated,
except
for
the
number
of
portfolios
overseen,
which
is
current
as
of
the
date
of
this
report.
Name
(Year
of
Birth)
Position
Held
With International
Funds 
Principal
Occupation(s) 
Mariel
Abreu
(1981)
Vice
President
Vice
President,
T.
Rowe
Price
and
T.
Rowe
Price
Group,
Inc.
Jason R.
Adams
(1979)
Executive
Vice
President
Vice
President,
T.
Rowe
Price
and
T.
Rowe
Price
Group,
Inc.
Ulle
Adamson,
CFA
(1979)
Executive
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Roy
H.
Adkins
(1970)
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Syed
H.
Ali
(1970)
Vice
President
Vice
President,
Price
Hong
Kong,
Price
Singapore,
and
T.
Rowe
Price
Group,
Inc.
Kennard
W.
Allen
(1977)
Vice
President
Vice
President,
T.
Rowe
Price
and
T.
Rowe
Price
Group,
Inc.
Paulina
Amieva
(1981)
Vice
President
Vice
President,
T.
Rowe
Price
and
T.
Rowe
Price
Group,
Inc.
Ziad
Bakri,
M.D.,
CFA
(1980)
Vice
President
Vice
President,
T.
Rowe
Price
and
T.
Rowe
Price
Group,
Inc.
Harishankar
Balkrishna
(1983)
Executive
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Sheena
L.
Barbosa
(1983)
Vice
President
Vice
President,
Price
Hong
Kong
and
T.
Rowe
Price
Group,
Inc.
Jason
A.
Bauer
(1979)
Vice
President
Vice
President,
T.
Rowe
Price
and
T.
Rowe
Price
Group,
Inc.
Luis
M.
Baylac
(1982)
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Unless
otherwise
noted,
officers
have
been
employees
of
T.
Rowe
Price
or
Price
International
for
at
least
5
years.
INTERESTED  DIRECTORS
(a)
(CONTINUED)
T.
ROWE
PRICE
Emerging
Europe
Fund
50
Name
(Year
of
Birth)
Position
Held
With International
Funds 
Principal
Occupation(s) 
R.
Scott
Berg,
CFA
(1972)
Executive
Vice
President
Vice
President,
T.
Rowe
Price,
T.
Rowe
Price
Group,
Inc.,
and
T.
Rowe
Price
Trust
Company
Steven
E.
Boothe,
CFA
(1977)
Vice
President
Vice
President,
T.
Rowe
Price
and
T.
Rowe
Price
Group,
Inc.
Peter
I.
Botoucharov
(1965)
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Tala
Boulos
(1984)
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Christopher
P.
Brown, CFA
(1977)
Vice
President
Vice
President,
T.
Rowe
Price
and
T.
Rowe
Price
Group,
Inc.
Armando
(Dino)
Capasso
(1974)
Chief
Compliance
Officer
and
Vice
President
Chief
Compliance
Officer
and
Vice
President,
T.
Rowe
Price
and
Price
Investment
Management;
Vice
President,
T.
Rowe
Price
Group,
Inc.;
formerly,
Chief
Compliance
Officer,
PGIM
Investments
LLC
and
AST
Investment
Services,
Inc.
(ASTIS)
(to
2022);
Chief
Compliance
Officer,
PGIM
Retail
Funds
complex
and
Prudential
Insurance
Funds
(to
2022);
Vice
President
and
Deputy
Chief
Compliance
Officer,
PGIM
Investments
LLC
and
ASTIS
(to
2019)
Shiu
Tak
(Sheldon)
Chan
(1981)
Vice
President
Vice
President,
Price
International
and
T.
Rowe
Price
Group,
Inc.
Andrew
Chang
(1983)
Vice
President
Vice
President,
Price
Singapore
and
T.
Rowe
Price
Group,
Inc.
Carolyn
Hoi
Che
Chu
(1974)
Vice
President
Vice
President,
Price
Hong
Kong
and
T.
Rowe
Price
Group,
Inc.
Vincent
Chung
(1988)
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International;
formerly,
Investment
Analyst/Trader,
Observatory
Capital
Management
LLP
(to
2019)
Archibald
Ciganer,
CFA
(1976)
Executive
Vice
President
Director
and
Vice
President,
Price
Japan;
Vice
President,
T.
Rowe
Price
Group,
Inc.
Richard
N.
Clattenburg,
CFA
(1979)
Executive
Vice
President
Vice
President,
Price
Singapore,
T.
Rowe
Price,
T.
Rowe
Price
Group,
Inc.,
Price
International,
and
T.
Rowe
Price
Trust
Company
Michael
F.
Connelly,
CFA
(1977)
Executive
Vice
President
Vice
President,
T.
Rowe
Price
and
T.
Rowe
Price
Group,
Inc.
Richard
de
los
Reyes
(1975)
Vice
President
Vice
President,
T.
Rowe
Price,
T.
Rowe
Price
Group,
Inc.,
and
T.
Rowe
Price
Trust
Company
Unless
otherwise
noted,
officers
have
been
employees
of
T.
Rowe
Price
or
Price
International
for
at
least
5
years.
OFFICERS
(CONTINUED)
T.
ROWE
PRICE
Emerging
Europe
Fund
51
Name
(Year
of
Birth)
Position
Held
With International
Funds 
Principal
Occupation(s) 
Michael
Della
Vedova
(1969)
Executive
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Iona
Dent,
CFA
(1991)
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Maria
Elena
Drew
(1973)
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Shawn
T.
Driscoll
(1975)
Vice
President
Vice
President,
T.
Rowe
Price,
T.
Rowe
Price
Group,
Inc.,
and
T.
Rowe
Price
Trust
Company
Alan
S.
Dupski,
CPA
(1982)
Principal
Financial
Officer,
Vice
President,
and
Treasurer
Vice
President,
Price
Investment
Management,
T.
Rowe
Price,
T.
Rowe
Price
Group,
Inc.,
and
T.
Rowe
Price
Trust
Company
Bridget
A.
Ebner
(1970)
Vice
President
Vice
President,
T.
Rowe
Price
and
T.
Rowe
Price
Group,
Inc.
David
J.
Eiswert,
CFA
(1972)
Executive
Vice
President
Vice
President,
T.
Rowe
Price
and
T.
Rowe
Price
Group,
Inc.
Cheryl
Emory
(1963)
Assistant
Secretary 
Assistant
Vice
President
and
Assistant
Secretary,
T.
Rowe
Price;
Assistant
Secretary,
T.
Rowe
Price
Group,
Inc.,
Price
Investment
Management,
Price
International,
Price
Hong
Kong,
Price
Singapore,
T.
Rowe
Price
Investment
Services,
Inc.,
T.
Rowe
Price
Retirement
Plan
Services,
Inc.,
and
T.
Rowe
Price
Trust
Company
Dawei
Feng
(1979)
Vice
President
Vice
President,
Price
Hong
Kong
and
T.
Rowe
Price
Group,
Inc.
Quentin
S.
Fitzsimmons
(1968)
Executive
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Justin
T.
Gerbereux,
CFA
(1975)
Vice
President
Vice
President,
T.
Rowe
Price,
T.
Rowe
Price
Group,
Inc.,
and
T.
Rowe
Price
Trust
Company
Aaron
Gifford,
CFA
(1987)
Vice
President
Vice
President,
T.
Rowe
Price
and
T.
Rowe
Price
Group,
Inc.
Vishnu
V.
Gopal
(1979)
Vice
President
Vice
President,
Price
International
and
T.
Rowe
Price
Group,
Inc.
Benjamin
Griffiths,
CFA
(1977)
Executive
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Shaoyu
Guo
(1992)
Vice
President
Vice
President,
Price
Hong
Kong
and
T.
Rowe
Price
Group,
Inc.;
formerly,
Economist,
J.P.
Morgan
(to
2020)
Unless
otherwise
noted,
officers
have
been
employees
of
T.
Rowe
Price
or
Price
International
for
at
least
5
years.
OFFICERS
(CONTINUED)
T.
ROWE
PRICE
Emerging
Europe
Fund
52
Name
(Year
of
Birth)
Position
Held
With International
Funds 
Principal
Occupation(s) 
Richard
L.
Hall
(1979)
Vice
President
Vice
President,
T.
Rowe
Price
and
T.
Rowe
Price
Group,
Inc.
Cheryl
Hampton,
CPA
(1969)
Vice
President
Vice
President,
T.
Rowe
Price,
T.
Rowe
Price
Group,
Inc.,
and
T.
Rowe
Price
Trust
Company;
formerly,
Tax
Director,
Invesco
Ltd.
(to
2021);
Vice
President,
Oppenheimer
Funds,
Inc.
(to
2019)
Nabil
Hanano,
CFA
(1984)
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Jeffrey
Holford,
Ph.D.,
ACA
(1972)
Vice
President
Vice
President,
T.
Rowe
Price
and
T.
Rowe
Price
Group,
Inc.
Stefan
Hubrich,
Ph.D.,
CFA
(1974)
Vice
President
Vice
President,
T.
Rowe
Price
and
T.
Rowe
Price
Group,
Inc.
Arif
Husain,
CFA
(1972)
Executive
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Michael D.
Jacobs
(1971)
Vice
President
Vice
President,
Price
Japan,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Randal
S.
Jenneke
(1971)
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.
Nina
P.
Jones,
CPA
(1980)
Vice
President
Vice
President,
T.
Rowe
Price
and
T.
Rowe
Price
Group,
Inc.
Yoichiro
Kai
(1973)
Vice
President
Vice
President,
Price
Singapore,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Jacob
H.
Kann,
CFA
(1987)
Vice
President
Vice
President,
T.
Rowe
Price
and
T.
Rowe
Price
Group,
Inc.
Jai
Kapadia
(1982)
Vice
President
Vice
President,
Price
Hong
Kong
and
T.
Rowe
Price
Group,
Inc.
Andrew
J.
Keirle
(1974)
Executive
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Benjamin
Kersse,
CPA
(1989)
Vice
President
Vice
President,
T.
Rowe
Price
and
T.
Rowe
Price
Trust
Company
Takanori
Kobayashi
(1981)
Vice
President
Vice
President,
Price
Japan,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Paul
J.
Krug,
CPA
(1964)
Vice
President
Vice
President,
T.
Rowe
Price,
T.
Rowe
Price
Group,
Inc.,
and
T.
Rowe
Price
Trust
Company
Christopher
J.
Kushlis,
CFA
(1976)
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Unless
otherwise
noted,
officers
have
been
employees
of
T.
Rowe
Price
or
Price
International
for
at
least
5
years.
OFFICERS
(CONTINUED)
T.
ROWE
PRICE
Emerging
Europe
Fund
53
Name
(Year
of
Birth)
Position
Held
With International
Funds 
Principal
Occupation(s) 
Shengrong
Lau
(1982)
Vice
President
Vice
President,
Price
Singapore
and
T.
Rowe
Price
Group,
Inc.
Lu
Liu
(1979)
Vice
President
Vice
President,
Price
Hong
Kong
and
T.
Rowe
Price
Group,
Inc.
Johannes
Loefstrand
(1988)
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Anh Lu
(1968)
Executive
Vice
President
Vice
President,
Price
Hong
Kong,
Price
International, and
T.
Rowe
Price
Group,
Inc.
Sebastien
Mallet
(1974)
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Jennifer Martin
(1972)
Vice
President
Vice
President,
T.
Rowe
Price
and
T.
Rowe
Price
Group,
Inc.
Ryan
Martyn
(1979)
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Colin
McQueen
(1967)
Executive
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International;
formerly,
Senior
Investment
Manager,
Global
Equities,
Sanlam
FOUR
Investments
UK
Limited
(to
2019)
Raymond
A.
Mills,
Ph.D.,
CFA
(1960)
Executive
Vice
President
Vice
President,
T.
Rowe
Price,
T.
Rowe
Price
Group,
Inc.,
Price
International,
and
T.
Rowe
Price
Trust
Company
Jihong
Min
(1979)
Executive
Vice
President
Vice
President,
Price
Singapore
and
T.
Rowe
Price
Group,
Inc.
Eric
C.
Moffett
(1974)
Executive
Vice
President
Vice
President,
Price
Singapore
and
T.
Rowe
Price
Group,
Inc.
Ivan
Morozov,
CFA
(1987)
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Samy
B.
Muaddi,
CFA
(1984)
Executive
Vice
President
Vice
President,
T.
Rowe
Price,
Price
International,
T.
Rowe
Price
Group,
Inc.,
and
T.
Rowe
Price
Trust
Company
Tobias
F. Mueller,
CFA
(1980)
Executive
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Razan
Nasser
(1985)
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International;
formerly,
Senior
Economist,
HSBC
Bank
Middle
East
Ltd
(to
2019)
Kenneth
A. Orchard
(1975)
Executive
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Unless
otherwise
noted,
officers
have
been
employees
of
T.
Rowe
Price
or
Price
International
for
at
least
5
years.
OFFICERS
(CONTINUED)
T.
ROWE
PRICE
Emerging
Europe
Fund
54
Name
(Year
of
Birth)
Position
Held
With International
Funds 
Principal
Occupation(s) 
Oluwaseun Oyegunle,
CFA
(1984)
Executive
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Fran
M.
Pollack-Matz
(1961)
Vice
President
and
Secretary 
Vice
President,
T.
Rowe
Price,
T.
Rowe
Price
Group,
Inc.,
T.
Rowe
Price
Investment
Services,
Inc., T.
Rowe
Price
Services,
Inc.,
and
T.
Rowe
Price
Trust
Company
Todd
Reese
(1990)
Vice
President
Vice
President,
T.
Rowe
Price
and
T.
Rowe
Price
Group,
Inc.
Melanie
A.
Rizzo
(1982)
Vice
President
Vice
President,
T.
Rowe
Price
and
T.
Rowe
Price
Group,
Inc.
David
L.
Rowlett,
CFA
(1975)
Vice
President
Vice
President,
T.
Rowe
Price
and
T.
Rowe
Price
Group,
Inc.
Federico
Santilli,
CFA
(1974)
Executive
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Nikolaj
Schmidt
(1975)
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Sebastian
Schrott
(1977)
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Richard
Sennett,
CPA
(1970)
Assistant
Treasurer
Vice
President,
T.
Rowe
Price,
T.
Rowe
Price
Group,
Inc.,
and
T.
Rowe
Price
Trust
Company
Weijie
(Vivian)
Si
(1983)
Executive
Vice
President
Vice
President,
T.
Rowe
Price
and
T.
Rowe
Price
Group,
Inc.
Scott
D.
Solomon,
CFA
(1981)
Executive
Vice
President
Vice
President,
T.
Rowe
Price, T.
Rowe
Price
Group,
Inc.,
and
T.
Rowe
Price
Trust
Company
Joshua
K.
Spencer,
CFA
(1973)
Vice
President
Vice
President,
T.
Rowe
Price,
T.
Rowe
Price
Group,
Inc.,
and
T.
Rowe
Price
Trust
Company
David
Stanley
(1963)
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Saurabh
Sud,
CFA
(1985)
Executive
Vice
President
Vice
President,
T.
Rowe
Price
and
T.
Rowe
Price
Group,
Inc.
Taymour
R.
Tamaddon,
CFA
(1976)
Vice
President
Vice
President,
T.
Rowe
Price,
T.
Rowe
Price
Group,
Inc.,
and
T.
Rowe
Price
Trust
Company
Ju
Yen
Tan
(1972)
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Sin
Dee
Tan,
CFA
(1979)
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Unless
otherwise
noted,
officers
have
been
employees
of
T.
Rowe
Price
or
Price
International
for
at
least
5
years.
OFFICERS
(CONTINUED)
T.
ROWE
PRICE
Emerging
Europe
Fund
55
Name
(Year
of
Birth)
Position
Held
With International
Funds 
Principal
Occupation(s) 
Siby
Thomas
(1979)
Executive
Vice
President
Vice
President,
T.
Rowe
Price
and
T.
Rowe
Price
Group,
Inc.
Justin
Thomson
(1968)
President
Director,
Price
Hong
Kong;
Vice
President,
T.
Rowe
Price
Group,
Inc.;
Director
and
Vice
President,
Price
International
Rupinder
Vig
(1979)
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Willem
Visser
(1979)
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Christopher Vost,
CFA
(1989)
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Zenon
Voyiatzis
(1971)
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Verena
E.
Wachnitz,
CFA
(1978)
Executive
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Megan
Warren
(1968)
Vice
President
OFAC
Sanctions
Compliance
Officer
and
Vice
President,
Price
Investment
Management;
Vice
President,
T.
Rowe
Price,
T.
Rowe
Price
Group,
Inc.,
T.
Rowe
Price
Retirement
Plan
Services,
Inc.,
T.
Rowe
Price
Services,
Inc.,
and
T.
Rowe
Price
Trust
Company
Hiroshi
Watanabe,
CFA
(1975)
Vice
President
Director
and
Vice
President,
Price
Japan;
Vice
President,
T.
Rowe
Price
Group,
Inc. 
James
Woodward,
CFA
(1974)
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Marta
Yago
(1977)
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Benjamin
T.
Yeagle
(1978)
Vice
President
Vice
President,
T.
Rowe
Price
and
T.
Rowe
Price
Group,
Inc.
Ernest
C.
Yeung,
CFA
(1979)
Executive
Vice
President
Director
and
Vice
President,
Price
Hong
Kong;
Vice
President,
T.
Rowe
Price
Group,
Inc.
Ellen
York
(1988)
Vice
President
Vice
President,
Price
Investment
Management
and
T.
Rowe
Price
Wenli
Zheng
(1979)
Executive
Vice
President
Vice
President,
Price
Hong
Kong
and
T.
Rowe
Price
Group,
Inc.
Unless
otherwise
noted,
officers
have
been
employees
of
T.
Rowe
Price
or
Price
International
for
at
least
5
years.
OFFICERS
(CONTINUED)
100
East
Pratt
Street
Baltimore,
MD
21202
T.
Rowe
Price
Investment
Services,
Inc.
Call
1-800-225-5132
to
request
a
prospectus
or
summary
prospectus;
each
includes
investment
objectives,
risks,
fees,
expenses,
and
other
information
that
you
should
read
and
consider
carefully
before
investing.
202312
-
3146014
F131-050
12/23


Item 1. (b) Notice pursuant to Rule 30e-3.

Not applicable.

Item 2. Code of Ethics.

The registrant has adopted a code of ethics, as defined in Item 2 of Form N-CSR, applicable to its principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. A copy of this code of ethics is filed as an exhibit to this Form N-CSR. No substantive amendments were approved or waivers were granted to this code of ethics during the period covered by this report.

Item 3. Audit Committee Financial Expert.

The registrant’s Board of Directors has determined that Ms. Teresa Bryce Bazemore qualifies as an audit committee financial expert, as defined in Item 3 of Form N-CSR. Ms. Bazemore is considered independent for purposes of Item 3 of Form N-CSR.

Item 4. Principal Accountant Fees and Services.

(a) – (d)    Aggregate fees billed for the last two fiscal years for professional services rendered to, or on behalf of, the registrant by the registrant’s principal accountant were as follows:

 

                    2023             2022  
 

Audit Fees

   $ 12,815                          $ 24,349  
 

Audit-Related Fees                     

     -           -  
 

Tax Fees

     -           -  
 

All Other Fees

     -           -  

Audit fees include amounts related to the audit of the registrant’s annual financial statements and services normally provided by the accountant in connection with statutory and regulatory filings. Audit-related fees include amounts reasonably related to the performance of the audit of the registrant’s financial statements and specifically include the issuance of a report on internal controls and, if applicable, agreed-upon procedures related to fund acquisitions. Tax fees include amounts related to services for tax compliance, tax planning, and tax advice. The nature of these services specifically includes the review of distribution calculations and the preparation of Federal, state, and excise tax returns. All other fees include the registrant’s pro-rata share of amounts for agreed-upon procedures in conjunction with service contract approvals by the registrant’s Board of Directors/Trustees.

(e)(1)   The registrant’s audit committee has adopted a policy whereby audit and non-audit services performed by the registrant’s principal accountant for the registrant, its investment adviser, and any entity controlling, controlled by, or under common control with the investment adviser that provides ongoing services to the registrant require pre-approval in advance at regularly scheduled audit committee meetings. If such a service is required between regularly scheduled audit committee meetings, pre-approval may be authorized by one audit committee member with ratification at the next scheduled audit committee meeting. Waiver of pre-approval for audit or non-audit services requiring fees of a de minimis amount is not permitted.

(2)   No services included in (b) – (d) above were approved pursuant to paragraph (c)(7)(i)(C) of Rule 2-01 of Regulation S-X.


(f)   Less than 50 percent of the hours expended on the principal accountant’s engagement to audit the registrant’s financial statements for the most recent fiscal year were attributed to work performed by persons other than the principal accountant’s full-time, permanent employees.

(g)   The aggregate fees billed for the most recent fiscal year and the preceding fiscal year by the registrant’s principal accountant for non-audit services rendered to the registrant, its investment adviser, and any entity controlling, controlled by, or under common control with the investment adviser that provides ongoing services to the registrant were $1,584,000 and $2,760,000, respectively.

(h)   All non-audit services rendered in (g) above were pre-approved by the registrant’s audit committee. Accordingly, these services were considered by the registrant’s audit committee in maintaining the principal accountant’s independence.

Item 5. Audit Committee of Listed Registrants.

Not applicable.

Item 6. Investments.

(a) Not applicable. The complete schedule of investments is included in Item 1 of this Form N-CSR.

(b) Not applicable.

Item 7. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.

Not applicable.

Item 8. Portfolio Managers of Closed-End Management Investment Companies.

Not applicable.

Item 9. Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.

Not applicable.

Item 10. Submission of Matters to a Vote of Security Holders.

There has been no change to the procedures by which shareholders may recommend nominees to the registrant’s board of directors.

Item 11. Controls and Procedures.

(a)   The registrant’s principal executive officer and principal financial officer have evaluated the registrant’s disclosure controls and procedures within 90 days of this filing and have concluded that the registrant’s disclosure controls and procedures were effective, as of that date, in ensuring that information required to be disclosed by the registrant in this Form N-CSR was recorded, processed, summarized, and reported timely.

(b)   The registrant’s principal executive officer and principal financial officer are aware of no change in the registrant’s internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.


Item 12. Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.

Not applicable.

Item 13. Exhibits.

 

(a)(1)    

The registrant’s code of ethics pursuant to Item 2 of Form N-CSR is attached.

     (2)    

Separate certifications by the registrant’s principal executive officer and principal financial officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 and required by Rule 30a-2(a) under the Investment Company Act of 1940, are attached.

     (3)    

Written solicitation to repurchase securities issued by closed-end companies: not applicable.

(b)        

A certification by the registrant’s principal executive officer and principal financial officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and required by Rule 30a-2(b) under the Investment Company Act of 1940, is attached.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

T. Rowe Price International Funds, Inc.
By  

/s/ David Oestreicher

            
  David Oestreicher  
  Principal Executive Officer  
Date       December 19, 2023  

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

By  

/s/ David Oestreicher

            
  David Oestreicher  
  Principal Executive Officer  
Date      

December 19, 2023

 

 

By  

/s/ Alan S. Dupski

            
  Alan S. Dupski  
  Principal Financial Officer  
Date      

December 19, 2023

 
 
EX-99.CERT 2 d935618dex99cert.htm 302 CERTIFICATIONS 302 CERTIFICATIONS

Item 13. (a)(2)

CERTIFICATIONS

I, David Oestreicher, certify that:

 

1.

I have reviewed this report on Form N-CSR of T. Rowe Price Emerging Europe Fund;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

 

  (a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and

 

  (d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer(s) and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and

 

  (b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: December 19, 2023      

/s/ David Oestreicher

      David Oestreicher
      Principal Executive Officer


CERTIFICATIONS

I, Alan S. Dupski, certify that:

 

1.

I have reviewed this report on Form N-CSR of T. Rowe Price Emerging Europe Fund;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

 

  (a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and

 

  (d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer(s) and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and

 

  (b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: December 19, 2023      

/s/ Alan S. Dupski

      Alan S. Dupski
      Principal Financial Officer
EX-99.906CE 3 d935618dex99906ce.htm 906 CERTIFICATIONS 906 CERTIFICATIONS

Item 13. (b)

CERTIFICATION UNDER SECTION 906 OF SARBANES-OXLEY ACT OF 2002

Name of Issuer: T. Rowe Price Emerging Europe Fund    

In connection with the Report on Form N-CSR for the above named Issuer, the undersigned hereby certifies, to the best of his knowledge, that:

 

  1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934;

 

  2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Issuer.

 

       Date: December 19, 2023      

/s/ David Oestreicher

        David Oestreicher
        Principal Executive Officer
  Date: December 19, 2023      

/s/ Alan S. Dupski

        Alan S. Dupski
        Principal Financial Officer
EX-99.CODE ETH 4 d935618dex99codeeth.htm CODE OF ETHICS CODE OF ETHICS

CODE OF ETHICS FOR PRINCIPAL EXECUTIVE AND SENIOR FINANCIAL

OFFICERS OF THE T. ROWE PRICE MUTUAL FUNDS AND EXCHANGE-

TRADED FUNDS

UNDER THE SARBANES-OXLEY ACT OF 2002

I.  General Statement. This Code of Ethics for the T. Rowe Price Mutual Funds and Exchange-Traded Funds (the “Price ETFs” and, together with the Mutual Funds, the “Price Funds”) has been designed to bring the Price Funds into compliance with the applicable requirements of the Sarbanes-Oxley Act of 2002 (the “Act”) and rules promulgated by the Securities and Exchange Commission thereunder (“Regulations”). This Price Funds’ Code of Ethics (the “S-O Code”) applies solely to the Principal Executive Officer, Principal Financial Officer, Principal Accounting Officer or Controller of, or persons performing similar functions for, a Price Fund (whether such persons are employed by a Price Fund or third party) (“Covered Officers”). The “Price Funds” shall include each mutual fund and ETF that is managed, sponsored and distributed by affiliates of T. Rowe Price Group, Inc. (“Group”). The investment managers to the Price Funds will be referred to as the “Price Fund Advisers.” A list of Covered Officers is attached as Exhibit A.

The Price Fund Advisers have, along with their parent, T. Rowe Price Group, Inc. (“Group”) also maintained a comprehensive Code of Ethics and Conduct (the “Group Code”) since 1972, which applies to all officers, directors and employees of the Price Funds, Group and its affiliates.

As mandated by the Act, Group has adopted a Code (the “Group S-O Code”), similar to the Price Funds S-O Code, which applies solely to its principal executive and senior financial officers. The Group S-O Code and the Price Funds S-O Code will be referred to collectively as the “S-O Codes”.

The Price Funds S-O Code has been adopted by the Price Funds in accordance with the Act and Regulations thereunder and will be administered in conformity with the disclosure requirements of Item 2 of Form N-CSR. The S-O Codes are attachments to the Group Code. In many respects the S-O Codes are supplementary to the Group Code, but the Group Code is administered separately from the S-O Codes, as the S-O Codes are from each other.

II.  Purpose of the Price Funds S-O Code. The purpose of the Price Funds S-O Code, as mandated by the Act and the Regulations, is to establish standards that are reasonably designed to deter wrongdoing and to promote:

Ethical Conduct. Honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships.

Disclosure. Full, fair, accurate, timely and understandable disclosure in reports and documents that the Price Funds file with, or submit to, the SEC and in other public communications made by the Price Funds.

Compliance. Compliance with applicable governmental laws, rules and regulations.

Reporting of Violations. The prompt internal reporting of violations of the Price Funds S-O Code to an appropriate person or persons identified in the Price Funds S-O Code.

Accountability. Accountability for adherence to the Price Funds S-O Code.

 

1


III.  Covered Officers Should Handle Ethically Actual and Apparent Conflicts of Interest.

Overview. Each Covered Officer owes a duty to the Price Funds to adhere to a high standard of honesty and business ethics and should be sensitive to situations that may give rise to actual as well as apparent conflicts of interest.

A “conflict of interest” occurs when a Covered Officer’s private interest interferes with the interests of, or his or her service to, the Price Funds. For example, a conflict of interest would arise if a Covered Officer, or a member of his or her family, receives improper personal benefits as a result of his or her position with a Price Fund.

Certain conflicts of interest covered by the Price Funds S-O Code arise out of the relationships between Covered Officers and the Price Funds and may already be subject to provisions regulating conflicts of interest in the Investment Company Act of 1940 (“Investment Company Act”), the Investment Advisers Act of 1940 (“Investment Advisers Act”) and the Group Code. For example, Covered Officers may not individually engage in certain transactions (such as the purchase or sale of securities or other property) with a Price Fund because of their status as “affiliated persons” of a Price Fund. The compliance programs and procedures of the Price Funds and Price Fund Advisers are designed to prevent, or identify and correct, violations of these provisions.

Although typically not presenting an opportunity for improper personal benefit, conflicts arise from, or as a result of, the contractual relationship between a Price Fund and its Price Fund Adviser (and its affiliates) of which the Covered Officers may also be officers or employees. As a result, the Price Funds S-O Code recognizes that the Covered Officers will, in the normal course of their duties (whether formally for the Price Funds or for the Price Fund Advisers, or for both), be involved in establishing policies and implementing decisions which will have different effects on these entities. The participation of the Covered Officers in such activities is inherent in the contractual relationship between each Price Fund and its respective Price Fund Adviser. Such participation is also consistent with the performance by the Covered Officers of their duties as officers of the Price Funds and, if consistent with the provisions of the Investment Company Act and the Investment Advisers Act, it will be deemed to have been handled ethically.

Other conflicts of interest are covered by the Price Funds and Price ETFs S-O Code, even if these conflicts of interest are not addressed by or subject to provisions in the Investment Company Act and the Investment Advisers Act.

Whenever a Covered Officer is confronted with a conflict of interest situation where he or she is uncertain as to the appropriate action to be taken, he or she should discuss the matter with the Chairperson of Group’s Ethics Committee or another member of the Committee.

Handling of Specific Types of Conflicts. Each Covered Officer (and close family members) must not:

Entertainment. Accept entertainment from any company with which any Price Fund or any Price Fund Adviser has current or prospective business dealings including portfolio companies, unless such entertainment is in full compliance with the policy on entertainment as set forth in the Group Code.

 

2


Gifts. Accept any gifts, except as permitted by the Group Code.

Improper Personal Influence. Use his or her personal influence or personal relationships improperly to influence investment decisions, brokerage allocations or financial reporting by the Price Funds to the detriment of any one or more of the Price Funds.

Taking Action at the Expense of a Price Fund. Cause a Price Fund to take action, or fail to take action, for the personal benefit of the Covered Officer rather than for the benefit of one or more of the Price Funds.

Misuse of Price Funds’ Transaction Information. Use knowledge of portfolio transactions made or contemplated for a Price Fund or any other clients of the Price Fund Advisers to trade personally or cause others to trade in order to take advantage of or avoid the market impact of such portfolio transactions; and in connection with Price ETFs that do not disclose portfolio holdings daily, use knowledge of pending changes to an ETF’s proxy portfolio holdings for such purposes.

Outside Business Activities. Engage in any outside business activity that detracts from a Covered Officer’s ability to devote appropriate time and attention to his or her responsibilities to a Price Fund.

Service Providers. Excluding Group and its affiliates, have any ownership interest in, or any consulting or employment relationship with, any of the Price Funds’ service providers, except that an ownership interest in public companies is permitted

Receipt of Payments. Have a direct or indirect financial interest in commissions, transaction charges, spreads or other payments paid by a Price Fund for effecting portfolio transactions or for selling or redeeming shares other than an interest (such as compensation or equity ownership) arising from the Covered Officer’s employment by Group or any of its affiliates.

Service as a Director or Trustee. Serve as a director, trustee or officer of any public or private company or a non-profit organization that issues securities eligible for purchase by any of the Price Funds, unless approval is obtained as required by the Group Code.

IV.  Covered Officers’ Specific Obligations and Accountabilities.

A.  Disclosure Requirements and Controls. Each Covered Officer must familiarize himself or herself with the disclosure requirements (Form N-lA registration statement, proxy (Schedule 14A), shareholder reports, Forms N-CEN, N-CSR, etc.) applicable to the Price Funds and the disclosure controls and procedures of the Price Fund and the Price Fund Advisers.

B.  Compliance with Applicable Law. It is the responsibility of each Covered Officer to promote compliance with all laws, rules and regulations applicable to the Price Funds and the Price Fund Advisers. Each Covered Officer should, to the extent appropriate within his or her area of responsibility, consult with other officers and employees of the Price Funds and the Price Fund Advisers and take other appropriate steps with the goal of promoting full, fair, accurate, timely and understandable disclosure in the reports and documents the Price Funds file with, or submit to, the SEC, and in other public

 

3


communications made by the Price Funds.

C.   Fair Disclosure. Each Covered Officer must not knowingly misrepresent, or cause others to misrepresent, facts about a Price Fund to others, whether within or outside the Price organization, including to the Price Fund’s directors and auditors, and to governmental regulators and self-regulatory organizations.

D.  Initial and Annual Affirmations. Each Covered Officer must:

1.  Upon adoption of the Price Funds S-O Code (or thereafter, as applicable, upon becoming a Covered Officer), affirm in writing that he or she has received, read, and understands the Price Funds S-O Code.

2.  Annually affirm that he or she has complied with the requirements of the Price Funds S-O Code.

E.  Reporting of Material Violations of the Price Funds S-O Code. If a Covered Officer becomes aware of any material violation of the Price Funds S-O Code or laws and governmental rules and regulations applicable to the operations of the Price Funds, he or she must promptly report the violation (“Report”) to the Chief Compliance Officer of the Price Funds (“CCO”). Failure to report a material violation will be considered itself a violation of the Price Funds S-O Code. The CCO is identified in the attached Exhibit B.

It is the Price Funds’ policy that no retaliation or other adverse action will be taken against any Covered Officer or other employee of a Price Fund, a Price Fund Adviser or their affiliates based upon any lawful actions of the Covered Officer or employee with respect to a Report made in good faith.

F.  Annual Disclosures. Each Covered Officer must report, at least annually, all affiliations or other relationships as called for in the “Annual Compliance Certification” for T. Rowe Price Group.

V.  Administration of the Price Funds S-O Code. The Ethics Committee is responsible for administering the Price Funds S-O Code and applying its provisions to specific situations in which questions are presented.

A.  Waivers and Interpretations. The Chairperson of the Ethics Committee has the authority to interpret the Price Funds S-O Code in any particular situation and to grant waivers where justified, subject to the approval of the Joint Audit Committee of the Price Funds. All material interpretations concerning Covered Officers will be reported to the Joint Audit Committee of the Price Funds at its next meeting. Waivers, including implicit waivers, to Covered Officers will be publicly disclosed as required in the Instructions to N-CSR. Pursuant to the definition in the Regulations, an implicit waiver means a Price Fund’s failure to take action within a reasonable period of time regarding a material departure from a provision of the Price Funds S-O Code that has been made known to an “executive officer” (as defined in Rule 3b-7 under the Securities Exchange Act of 1934) of a Price Fund. An executive officer of a Price Fund includes its president and any vice-president in charge of a principal business unit, division or function.

B.  Violations/Investigations. The following procedures will be followed in

 

4


investigating and enforcing the Price Funds S-O Code:

1.  The CCO will take or cause to be taken appropriate action to investigate any potential or actual violation reported to him or her.

2.  The CCO, after consultation if deemed appropriate with Outside Counsel to the Price Funds, will make a recommendation to the appropriate Price Funds Board regarding the action to be taken with regard to each material violation. Such action could include any of the following: a letter of censure or suspension, a fine, a suspension of trading privileges or termination of officership or employment. In addition, the violator may be required to surrender any profit realized (or loss avoided) from any activity that is in violation of the Price Funds S-O Code.

3.  Investigations of Whistleblower complaints related to Price Funds will be handled in accordance with the T. Rowe Price Global Whistleblower Policy.

VI.  Amendments to the Price Funds S-O Code. Except as to the contents of Exhibit A and Exhibit B, the Price Funds S-O Code may not be materially amended except in written form, which is specifically approved or ratified by a majority vote of each Price Fund Board, including a majority of the independent directors on each Board.

VII.  Confidentiality. All reports and records prepared or maintained pursuant to the Price Funds S-O Code will be considered confidential and shall be maintained and protected accordingly. Except as otherwise required by law, the Price Funds S-O Code or as necessary in connection with regulations under the Price Funds S-O Code, such matters shall not be disclosed to anyone other than the directors of the appropriate Price Fund Board, Outside Counsel to the Price Funds, members of the Ethics Committee and the CCO and authorized persons on his or her staff.

Adoption Date:    10/22/03

Last Revised:       05/11/2022 (Exhibit B revised)

 

5


Exhibit A

Persons Covered by the Price Funds and

Price ETFs S-O Code of Ethics

David Oestreicher, Executive Vice President and Principal Executive Officer

Alan S. Dupski, Treasurer and Principal Financial Officer

Exhibit B

Dino Capasso, Chief Compliance Officer

 

6